<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Genomics</journal-id><journal-id journal-id-type="publisher-id">CG</journal-id><journal-title>Current Genomics</journal-title><issn pub-type="ppub">1389-2029</issn><issn pub-type="epub">1875-5488</issn><publisher><publisher-name>Bentham Science Publishers Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">CG-8-398</article-id><article-id pub-id-type="doi">10.2174/138920207783406488</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The <italic>GNAS</italic> Locus: Quintessential Complex Gene Encoding Gs&#x003b1;, XL&#x003b1;s, and other Imprinted Transcripts</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bastepe</surname><given-names>Murat</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff">Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA</aff><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Murat Bastepe, Endocrine Unit, Massachusetts General Hospital, 50 Blossom St. Thier 10, Boston, MA 02114, USA; E-mail: <email xlink:href="bastepe@helix.mgh.harvard.edu">bastepe@helix.mgh.harvard.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2007</year></pub-date><volume>8</volume><issue>6</issue><fpage>398</fpage><lpage>414</lpage><history><date date-type="received"><day>19</day><month>8</month><year>2007</year></date><date date-type="rev-recd"><day>22</day><month>9</month><year>2007</year></date><date date-type="accepted"><day>28</day><month>9</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9;2007 Bentham Science Publishers Ltd.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.5/">http://creativecommons.org/licenses/by/2.5/</uri>) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>The currently estimated number of genes in the human genome is much smaller than previously predicted. As an explanation for this disparity, most individual genes have multiple transcriptional units that represent a variety of biologically important gene products. <italic>GNAS</italic> exemplifies a gene of such complexity. One of its products is the &#x003b1;-subunit of the stimulatory heterotrimeric G protein (Gs&#x003b1;), a ubiquitous signaling protein essential for numerous different cellular responses. Loss-of-function and gain-of-function mutations within Gs&#x003b1;-coding <italic>GNAS</italic> exons are found in various human disorders, including Albright&#x02019;s hereditary osteodystrophy, pseudohypoparathyroidism, fibrous dysplasia of bone, and some tumors of different origin. While Gs&#x003b1; expression in most tissues is biallelic, paternal Gs&#x003b1; expression is silenced in a small number of tissues, playing an important role in the development of phenotypes associated with <italic>GNAS</italic> mutations. Additional products derived exclusively from the paternal <italic>GNAS</italic> allele include XL&#x003b1;s, a protein partially identical to Gs&#x003b1;, and two non-coding RNA molecules, the A/B transcript and the antisense transcript. The maternal <italic>GNAS</italic> allele leads to NESP55, a chromogranin-like neuroendocrine secretory protein. <italic>In vivo</italic> animal models have demonstrated the importance of each of the exclusively imprinted <italic>GNAS</italic> products in normal mammalian physiology. However, although one or more of these products are also disrupted by most naturally occurring <italic>GNAS</italic> mutations, their roles in disease pathogenesis remain unknown. To further our understanding of the significance of this gene in physiology and pathophysiology, it will be important to elucidate the cellular roles and the mechanisms regulating the expression of each <italic>GNAS</italic> product.</p></abstract></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The first draft of the human genome DNA sequence was reported in 2001 independently by the Human Genome Project and Celera Genomics [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2"> 2</xref>]. Since this important landmark in medical research, the entire research community has had access to a wealth of information that would otherwise have taken many years to gather, resulting in a tremendous acceleration of virtually all research studies that involve human biology or disease. With updates of the project, the sequence is nearly complete [<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4"> 4</xref>]. It is interesting, however, that the number of genes in the human genome appears to be much smaller than initially estimated. Although the exact number of genes in the genome still remains unknown, more recent estimate for the number of protein-coding genes is between 20,000 and 25,000 [<xref ref-type="bibr" rid="R5">5</xref>], which markedly differs from the previously predicted number of approximately 100,000 [<xref ref-type="bibr" rid="R6">6</xref>-<xref ref-type="bibr" rid="R9">9</xref>]. The currently estimated gene number, of course, appears quite small, considering the complexity of our species. However, the difference between the older and most recent predictions of the gene number can be accounted for by the presence of multiple transcriptional units associated with many individual genes. In fact, the total number of proteins encoded by the human genome may be similar to, if not higher than, the past estimates of the gene number. This review focuses on the <italic>GNAS</italic> locus, which exemplifies a complex gene with multiple gene products derived through alternative promoter use and alternative pre-mRNA splicing.</p></sec><sec><title>THE COMPLEX <italic>GNAS</italic> LOCUS AND Gs&#x003b1;</title><p>The human <italic>GNAS</italic> locus maps to the telomeric end of the long arm of chromosome 20 (20q13.2-20q13.3) [<xref ref-type="bibr" rid="R10">10</xref>-<xref ref-type="bibr" rid="R12">12</xref>], while its mouse ortholog is located in distal chromosome 2 [<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14"> 14</xref>]. <italic>GNAS</italic> in humans and mice appear structurally and functionally similar to one and other. This locus has multiple promoters and differentially methylated regions (DMR) and gives rise to non-coding RNA molecules and transcripts that encode functional proteins (Fig. <bold><xref ref-type="fig" rid="F1">1</xref></bold>). Furthermore, nearly all <italic>GNAS</italic> products show parent-of-origin specific expression. Among the multiple products derived from <italic>GNAS</italic>, the best characterized protein is the &#x003b1;-subunit of the heterotrimeric stimulatory G protein (Gs&#x003b1;), which has at least five variants that result from alternative pre-mRNA splicing. Derived from distinct promoters are at least four different additional <italic>GNAS</italic> products, including the neuroendocrine secretory protein 55 (NESP55), the extra-large variant of Gs&#x003b1; (XL&#x003b1;s), the A/B transcript, and the <italic>GNAS</italic> antisense transcript. Most of these additional transcripts also undergo alternative splicing and, thus, have different variants.</p><p>Gs&#x003b1; is a ubiquitous protein whose activity is essential for the cellular actions of many neurotransmitters, autocrine/paracrine factors, and hormones. As in &#x003b1;-subunits of other heterotrimeric G proteins, activation of Gs&#x003b1; by an agonist-occupied cell surface receptor results in a GDP-GTP exchange on Gs&#x003b1;, causing dissociation of the latter from G&#x003b2;&#x003b3; subunits and, thereby, allowing both Gs&#x003b1; and G&#x003b2;&#x003b3; to stimulate their respective effectors. GTP-bound, free Gs&#x003b1; can directly activate several different effectors, including Src tyrosine kinase [<xref ref-type="bibr" rid="R15">15</xref>] and certain Ca-channels [<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17"> 17</xref>]. However,by far the most ubiquitous and the most extensively investigated effector molecule stimulated by Gs&#x003b1; is adenylyl cyclase, an integral membrane protein that catalyzes the synthesis of the ubiquitous second messenger cyclic AMP (cAMP), thereby triggering an intracellular signaling cascade that brings about an agonist- and cell-specific response. The activation of adenylyl cyclase and other effectors by Gs&#x003b1; is tightly regulated. The intrinsic GTP hydrolase (GTPase) activity of Gs&#x003b1; reverts the GTP-bound Gs&#x003b1; to its GDP-bound state and, thereby, results in the re-assembly of the G protein heterotrimer, which can no longer mediate effector stimulation. Mutagenesis experiments often lead to alteration in activity and/or subcellular distribution, indicating that changes are non-tolerable at many of the amino acid positions. Particularly, Arg<sup>201</sup> and Gln<sup>227</sup> are critical, since modifications of these residues, such as ADP-ribosylation of Arg<sup>201</sup> that can be induced by cholera toxin or mutations at either residue, lead to inhibition of the GTPase activity and, therefore, render Gs&#x003b1; constitutively active [<xref ref-type="bibr" rid="R18">18</xref>-<xref ref-type="bibr" rid="R21">21</xref>]. The receptor and GTPase dependent activation cycle of Gs&#x003b1;, structural features of Gs&#x003b1; protein, and the roles of specific Gs effectors have been reviewed in more detail elsewhere [<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23"> 23</xref>].</p><p>Gs&#x003b1; is encoded by 13 exons [<xref ref-type="bibr" rid="R24">24</xref>], but due to alternative pre-mRNA splicing, the Gs&#x003b1; transcript has several variants (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). The long and the short Gs&#x003b1; variants (Gs&#x003b1;-L and Gs&#x003b1;-S, respectively) differ from each other by the inclusion or exclusion of 45 nucleotides derived from exon 3 [<xref ref-type="bibr" rid="R24">24</xref>-<xref ref-type="bibr" rid="R26">26</xref>]. Nearly all tissues express both of these Gs&#x003b1; variants, which are typically detected as 52- and 45-kDa protein bands on Western blots. In addition, each Gs&#x003b1; form either includes or excludes a CAG tri-nucleotide (encoding serine) at the start of exon 4. Some investigations have revealed small, but potentially important, differences between the activities of Gs&#x003b1;-L and Gs&#x003b1;-S. For example, Gs&#x003b1;-L has been demonstrated to have a greater ability to transmit receptor signaling than Gs&#x003b1;-S when partially purified proteins from rabbit liver were examined [<xref ref-type="bibr" rid="R27">27</xref>], although the opposite was suggested in an assay system using cultured pancreatic islet cells [<xref ref-type="bibr" rid="R28">28</xref>]. Moreover, Gs&#x003b1;-L appears to release GDP ~2-fold faster than Gs&#x003b1;-S [<xref ref-type="bibr" rid="R29">29</xref>], and consistent with that finding, study of fusion proteins involving the &#x003b2;2-adrenergic receptor and either Gs&#x003b1;-L or Gs&#x003b1;-S has shown higher constitutive activity of the receptor when it is associated with Gs&#x003b1;-L [<xref ref-type="bibr" rid="R30">30</xref>]. In addition, differences in the subcellular trafficking of these two variants have been reported in response to activation by agonist, forskolin (a direct activator of adenylyl cyclase), or GTP&#x003b3;S (a stable GTP analog) [<xref ref-type="bibr" rid="R31">31</xref>-<xref ref-type="bibr" rid="R33">33</xref>]. Currently, it remains unclear whether these differences translate into biologically significant effects, such as divergence in the variety of effectors and/or the efficiency of effector activation. An important recent finding regarding the long and short Gs&#x003b1; forms is that, for the first time, an inactivating mutation in exon 3 has been identified in a patient with pseudohypoparathyroidism type-Ia [<xref ref-type="bibr" rid="R34">34</xref>], a disorder known to be caused by inactivating mutations in Gs&#x003b1;-coding <italic>GNAS</italic> exons (see below). The patient with the exon 3 mutation has an apparently mild form of this disorder, consistent with the disruption of only one of the two main Gs&#x003b1; variants, i.e. Gs&#x003b1;-L [<xref ref-type="bibr" rid="R34">34</xref>]. It is conceivable that, depending on the effector selectivity and relative expression levels of Gs&#x003b1;-L and Gs&#x003b1;-S in different tissues, this mutation impairs agonist responses in an effector- and tissue-specific manner. This possibility remains unexplored.</p><p>Alternative pre-mRNA splicing leads to another Gs&#x003b1; variant, termed Gs&#x003b1;-N1 (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). Identified first in the brain, Gs&#x003b1;-N1 is truncated in the C-terminus due to splicing of exon 3 (or exon 2 in the case of Gs&#x003b1;-S) onto a distinct exon containing an in-frame termination codon [<xref ref-type="bibr" rid="R35">35</xref>]. Exon N1 is located between exons 3 and 4. Gs&#x003b1;-N1 lacks most functional domains of Gs&#x003b1;, and therefore, it is probably unable to function in a way similar to the latter. Its cellular role and its biological significance remain unknown.</p></sec><sec><title>TISSUE-SPECIFIC Gs&#x003b1; IMPRINTING</title><p>Several studies have demonstrated that the expression of Gs&#x003b1; in most fetal and adult tissues is biallelic, consistent with the absence of differential methylation at its promoter [<xref ref-type="bibr" rid="R36">36</xref>-<xref ref-type="bibr" rid="R39">39</xref>]. However, in some human and mouse tissues, Gs&#x003b1; expression is predominantly maternal, i.e. paternal Gs&#x003b1; expression is silenced. For example, in the renal cortex, mice with paternal disruption of <italic>Gnas</italic> exon 2 exhibit Gs&#x003b1; mRNA and protein levels that are similar to those seen in wild-type littermates, whereas mice with maternal disruption of <italic>Gnas</italic> exon 2 are nearly devoid of Gs&#x003b1; mRNA and protein [<xref ref-type="bibr" rid="R40">40</xref>], indicating that renal cortical Gs&#x003b1; expression is derived mostly from the maternal allele. This monoallelic, parent-of-origin specific Gs&#x003b1; expression occurs in a tissue-specific manner, as both mice with the maternal disruption and mice with the paternal disruption show Gs&#x003b1; levels in the renal medulla that are about 50% of the levels seen in wild-type littermates [<xref ref-type="bibr" rid="R40">40</xref>]. Similar findings have been reported recently in mice heterozygous for either paternal or maternal disruption of <italic>Gnas</italic> exon 1, and these studies additionally demonstrated that Gs&#x003b1; expression is also predominantly maternal in the thyroid [<xref ref-type="bibr" rid="R41">41</xref>]. Consistent with these findings, the active maternal Gs&#x003b1; promoter shows a greater ratio of tri- to dimethylated histone-3 Lys<sup>4</sup> compared to the silenced paternal promoter in the proximal tubule, whereas the amount of methylated histones is similar in maternal and paternal Gs&#x003b1; promoters in liver, a tissue in which Gs&#x003b1; is biallelic [<xref ref-type="bibr" rid="R42">42</xref>].</p><p>Monoallelic, maternal Gs&#x003b1; expression has also been documented in human tissues through the analysis of a single nucleotide polymorphism located in exon 5. Thus, Gs&#x003b1; is predominantly maternal in thyroid, pituitary, and ovaries [<xref ref-type="bibr" rid="R43">43</xref>-<xref ref-type="bibr" rid="R45">45</xref>]. On the other hand, biallelic Gs&#x003b1; expression has been demonstrated in lymphocytes, adrenal, adipocytes, and bone cells [<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R46"> 46</xref>,<xref ref-type="bibr" rid="R47"> 47</xref>]. The tissue-specific, imprinted expression of Gs&#x003b1; has important implications in the pathogenesis of diseases caused by mutations within <italic>GNAS</italic>, particularly pseudohypoparathyroidism (see below).</p><p>Several Gs&#x003b1; knockout mouse models have been generated in order to study the role of Gs&#x003b1; <italic>in vivo</italic>. The mouse models with universal Gs&#x003b1; disruption will be discussed below in the context of human diseases that are caused by heterozygous inactivating mutations within one of the 13 exons encoding this protein. In addition, Gs&#x003b1; has been conditionally ablated, through the use of the Cre-Flox technology, in specific tissues including liver, cartilage, bone, and glomerulus, confirming the absolute requirement of Gs&#x003b1; in the proper function of these tissues [<xref ref-type="bibr" rid="R48">48</xref>-<xref ref-type="bibr" rid="R51">51</xref>].</p></sec><sec><title>NOVEL IMPRINTED GENE PRODUCTS OF THE <italic>GNAS</italic> LOCUS</title><p>Human and mouse studies over the past several years have identified novel promoters and exons within <italic>GNAS</italic>, thereby unveiling the previously unrecognized complexity of this gene locus. The sense strand comprises at least three promoters besides the promoter driving the expression of the aforementioned Gs&#x003b1; variants (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). In addition, there is at least one promoter that shows activity on the antisense strand. All of the recently described promoters are located within CpG islands that show differential, parent-of-origin specific methylation. Therefore, the <italic>GNAS</italic> locus harbors a total of four distinct DMRs. Consistent with the differential methylation of its promoter, each of the additional <italic>GNAS</italic> product shows an imprinted expression profile in nearly all tissues investigated in that regard.</p><sec><title>NESP55</title><p>The most upstream of the different <italic>GNAS</italic> promoters with respect to the promoter of Gs&#x003b1; drives the expression of NESP55, a neuroendocrine secretory protein with an apparent molecular mass of 55,000 (Fig. <bold><xref ref-type="fig" rid="F1">1</xref></bold>). The NESP55 promoter is differentially methylated and active on the non-methylated maternal allele only [<xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R52"> 52</xref>]. In humans, NESP55 protein is encoded by a single exon, while in mice, the ORF consists of two separate exons; however, in both species, these exons splice onto Gs&#x003b1; exons 2-13, which comprise the 3&#x02019; untranslated region (UTR) [<xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R52"> 52</xref>]. The predicted molecular mass of NESP55 is 28 kDa, but it has the same electrophoretic mobility as a protein of 55 kDa [<xref ref-type="bibr" rid="R53">53</xref>]. NESP55 is a chromogranin-like protein expressed in neuroendocrine tissues, peripheral and central nervous system, and some endocrine tissues [<xref ref-type="bibr" rid="R53">53</xref>-<xref ref-type="bibr" rid="R56">56</xref>]. It is associated with the constitutive secretory pathway [<xref ref-type="bibr" rid="R57">57</xref>] and can be located in cholinergic, peptidergic, and adrenergic neurons [<xref ref-type="bibr" rid="R58">58</xref>]. In AtT20 cells, a corticotroph-like cell line, NESP55 has been shown to be exported out into the medium, a process which can be blocked markedly by lowering the temperature and modestly by treatment with a cAMP analog (8-bromo-cAMP) [<xref ref-type="bibr" rid="R59">59</xref>]. In different tissues, differential post-translational processing of NESP55 leads to smaller peptides, which appear to accumulate during antegrade transport of this protein along the axon [<xref ref-type="bibr" rid="R58">58</xref>]. One of the putative peptide products, Leu-Ser-Ala-Leu (LSAL), which may be produced by prohormone convertase cleavage, has been identified as an endogenous antagonist of the serotonergic 5-HT1B receptor subtype [<xref ref-type="bibr" rid="R53">53</xref>], although this possibility and its potential biological significance have yet to be investigated.</p><p>A knockout of the Nesp55 transcript has been generated in mice through introduction, by homologous recombination in ES cells, of a small deletion at the translation initiation site [<xref ref-type="bibr" rid="R60">60</xref>]. This mutation leads to a complete ablation of Nesp55 protein after maternal transmission, without affecting the expression of other <italic>Gnas</italic> transcripts. Nesp55 knockout mice appear to have no overt phenotypic abnormalities and are fertile. However, behavioral studies of these mice using several distinct tasks have revealed increased reactivity to novel environments, but these mice do not differ from wild-type mice in general locomotion and anxiety. Although the role of this protein at the molecular level remains to be explored, the findings in the Nesp55 deficient mice appear to be consistent with the localization of this protein in specific parts of the central nervous system, particularly noradrenergic locus coeruleus [<xref ref-type="bibr" rid="R61">61</xref>]. In humans, loss of NESP55 expression occurs as a result of a gain of methylation at its promoter (observed in some patients with pseudohypoparathyroidism type-Ib). This defect, however, does not appear to lead to an obvious phenotype, because no significant differences have been identified between patients with the gain of NESP55 methylation and those without this epigenetic alteration [<xref ref-type="bibr" rid="R62">62</xref>,<xref ref-type="bibr" rid="R63"> 63</xref>].</p></sec><sec><title>XL&#x003b1;s</title><p>Another promoter, located ~11 kb downstream of the NESP55 promoter, drives the expression of XL&#x003b1;s mRNA, which encodes a protein with partial identity to Gs&#x003b1; (Fig. <bold><xref ref-type="fig" rid="F1">1</xref></bold>). As in NESP55, the XL&#x003b1;s transcript uses a novel first exon (exon XL) that splices onto exons 2-13 of Gs&#x003b1; [<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R52"> 52</xref>]. Unlike in the case of NESP55, however, the in-frame termination codon for the XL&#x003b1;s transcript is the same as for Gs&#x003b1;, making the encoded XL&#x003b1;s and Gs&#x003b1; proteins identical over a long C-terminal stretch [<xref ref-type="bibr" rid="R64">64</xref>]. Exon XL and the XL&#x003b1;s promoter are located in a CpG island methylated on the maternal allele [<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R52"> 52</xref>]. Consistent with this epigenetic mark, XL&#x003b1;s is derived exclusively from the paternal allele in all investigated tissues [<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R52"> 52</xref>,<xref ref-type="bibr" rid="R65"> 65</xref>]; however, variable biallelic expression of XL&#x003b1;s has been recently demonstrated in clonal bone stromal cells [<xref ref-type="bibr" rid="R47">47</xref>]. Most abundant expression of XL&#x003b1;s is detected in neuroendocrine tissues, particularly pituitary, but the expression of its mRNA is readily detected by Northern blot or RT-PCR in various tissues, including brain, pancreas, heart, kidney, and adipose tissue [<xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R64"> 64</xref>,<xref ref-type="bibr" rid="R66"> 66</xref>,<xref ref-type="bibr" rid="R67"> 67</xref>]. As demonstrated in the rat nervous system, XL&#x003b1;s expression is developmentally regulated [<xref ref-type="bibr" rid="R68">68</xref>].</p><p>Because XL&#x003b1;s shares significant amino acid identity with Gs&#x003b1;, it comprises most domains of the latter shown to be functionally important. Furthermore, the C-terminal end of the XL domain has significant homology to the exon 1 encoded portion of Gs&#x003b1;. Consistent with the high degree of overall similarity between XL&#x003b1;s and Gs&#x003b1;, various studies have demonstrated that XL&#x003b1;s is able to act in a manner similar to Gs&#x003b1; <italic>in vitro</italic>. First, XL&#x003b1;s show enhanced ADP ribosylation and an increased sucrose-density sedimentation rate upon addition of the G&#x003b2;&#x003b3; subunits, indicating that XL&#x003b1;s is able to form a heterotrimer [<xref ref-type="bibr" rid="R69">69</xref>]. Second, expression of an XL&#x003b1;s mutant carrying the homolog of the Gs&#x003b1; Gln<sup>227</sup> mutation results in elevated cAMP formation, indicating that XL&#x003b1;s can stimulate adenylyl cyclase at least in the basal state [<xref ref-type="bibr" rid="R69">69</xref>]. Third, XL&#x003b1;s can mediate receptor-stimulated cAMP formation when overexpressed in opossum kidney cells that show endogenous Gs&#x003b1; expression [<xref ref-type="bibr" rid="R70">70</xref>] and in mouse embryonic fibroblasts that endogenously lack Gs&#x003b1; and XL&#x003b1;s due to homozygous disruption of <italic>Gnas</italic> exon 2 [<xref ref-type="bibr" rid="R71">71</xref>]. Finally, mutations that impair Gs&#x003b1; activity have similar effects on XL&#x003b1;s activity when introduced into the backbone of the latter [<xref ref-type="bibr" rid="R70">70</xref>]. Interestingly, however, beta-adrenergic stimulation seemingly fails to elicit cAMP generation in XL&#x003b1;s transfected S49 lymphoma cells that are also Gs&#x003b1; deficient (cyc<sup>-</sup> clone) [<xref ref-type="bibr" rid="R69">69</xref>]. Furthermore, attempts to show coupling of XL&#x003b1;s to receptors have failed, using PC12 cells transfected with XL&#x003b1;s cDNA and pituitary membranes [<xref ref-type="bibr" rid="R69">69</xref>]. Taken together, these findings suggest that the Gs&#x003b1;-like activity of XL&#x003b1;s may be cell specific.</p><p>As illustrated in Fig. (<bold><xref ref-type="fig" rid="F3">3A</xref></bold>), XL&#x003b1;s has several different variants. Similar to Gs&#x003b1;, it uses exon 3 alternatively, thus having at least a long and a short variant. In addition, analogous to Gs&#x003b1;-N1, a C-terminally truncated XL&#x003b1;s variant, termed XL&#x003b1;s-N1, also exists. Human XL&#x003b1;s-N1 appears to have a subvariant produced by inclusion of sequences from two additional exons, A20 and A21, located immediately following exon XL [<xref ref-type="bibr" rid="R36">36</xref>]. A similar subvariant has also been demonstrated for rat XL&#x003b1;s-N1 [<xref ref-type="bibr" rid="R66">66</xref>]. The introduction of these additional sequences into XL&#x003b1;s-N1 results in a frame-shift, leading to a putative protein with partial identity to XL&#x003b1;s but not to Gs&#x003b1;. Functional significance of XL&#x003b1;s-N1 and its variants remains unknown.</p><p>There is evidence for the existence of a long XL&#x003b1;s transcript, termed XXL&#x003b1;s, which extends in the 5&#x02019; direction (Fig. <bold><xref ref-type="fig" rid="F3">3A</xref></bold>). The XXL&#x003b1;s transcript is supported by Est databases and a single study that could amplify portions of the XXL&#x003b1;s transcript by RT-PCR [<xref ref-type="bibr" rid="R72">72</xref>]. A long XL&#x003b1;s transcript has also been revealed by Northern blot in mouse heart and adipose tissue [<xref ref-type="bibr" rid="R67">67</xref>]. In fact, based on existing data, the translation initiation codon for XL&#x003b1;s does not match with that corresponding to the longest open reading frame (ORF), making it likely that an N-terminally extended XL&#x003b1;s variant is expressed at least in some tissues. Est databases also suggest the existence of transcripts that correspond to XXL&#x003b1;s-N1, but neither the role of XXL&#x003b1;s nor the role of XXL&#x003b1;s-N1 is currently known. Interestingly, however, unlike the XL domain in XL&#x003b1;s and XL&#x003b1;s-N1-- the portion encoded by exon XL -- the N-terminally extended part in XXL&#x003b1;s and XXL&#x003b1;s-N1 is highly conserved among mammals, suggesting that it may represent a functionally significant domain.</p><p>The XL&#x003b1;s mRNA has a second ORF that encodes another protein termed ALEX (for <underline>al</underline>ternative protein <underline>e</underline>ncoded by <underline>X</underline>L&#x003b1;s mRNA), which uses a termination codon located within exon XL and is, therefore, smaller than XL&#x003b1;s (Fig. <bold><xref ref-type="fig" rid="F3">3B</xref></bold>). <italic>In vitro</italic> studies have shown that ALEX, which has a predicted molecular mass of 38 kDa, can interact with XL&#x003b1;s [<xref ref-type="bibr" rid="R73">73</xref>,<xref ref-type="bibr" rid="R74"> 74</xref>]. An insertion polymorphism within XL&#x003b1;s mRNA, affecting both proteins, appears to impair this interaction, a finding that has been offered as an explanation as to why some individuals carrying this insertion polymorphism show elevated agonist-induced cAMP accumulation in platelets [<xref ref-type="bibr" rid="R74">74</xref>]. However, this increased agonist responsiveness could also result from elevated Gs&#x003b1; levels, which was demonstrated in several individuals who carried the same insertion polymorphism and had increased bleeding tendency [<xref ref-type="bibr" rid="R75">75</xref>]. Hence, the significance of XL&#x003b1;s-ALEX interaction on XL&#x003b1;s or Gs&#x003b1; function remains to be clarified. Of note, this alternative ORF also extends in to the XXL&#x003b1;s mRNA, generating a putative N-terminally extended ALEX variant, termed ALEXX [<xref ref-type="bibr" rid="R72">72</xref>]; however, there are currently no available experimental data to suggest that this protein actually exists.</p><p>Exon XL has been disrupted in mice through introduction of a small deletion into the beginning part of both XL&#x003b1;s and ALEX ORF; this disruption appears to preserve the imprinted expression of other <italic>Gnas</italic> transcripts [<xref ref-type="bibr" rid="R67">67</xref>]. The mice with paternal inheritance of the disrupted XL&#x003b1;s allele (<italic>Gnas</italic>xl knockout mice) lack XL&#x003b1;s expression, consistent with the exclusive paternal expression of the XL&#x003b1;s transcript. The <italic>Gnas</italic>xl knockout pups show defective suckling, hypoglycemia, growth retardation, and early postnatal mortality. Despite having hypoglycemia, the <italic>Gnas</italic>xl knockout mice show reduced glucagon levels and inappropriately normal serum catecholamine and cortisol levels, suggesting a possible impairment of the physiological responses to hypoglycemia. When crossed into the CD1 background, about 20% of the <italic>Gnas</italic>xl knockout animals survive with an apparently normal life-span. However, these mice display increased glucose tolerance and insulin sensitivity, as well as a hypermetabolic state associated with reduced adiposity and hypolipidemia [<xref ref-type="bibr" rid="R67">67</xref>]. In addition, circulating levels of norepinephrine is elevated in these animals, indicating increased sympathetic nervous system activity, which explains, at least in part, the defects in the energy metabolism [<xref ref-type="bibr" rid="R76">76</xref>]. On the other hand, adipocyte-autonomous factors appear less likely to be involved in these phenotypes, because XL&#x003b1;s is not expressed in the adipocytes of adult wild-type mice [<xref ref-type="bibr" rid="R76">76</xref>].</p><p>The genetic alteration in the <italic>Gnas</italic>xl knockout mice is predicted to disrupt not only XL&#x003b1;s but also XL&#x003b1;s-N1, ALEX, XXL&#x003b1;s, XXL&#x003b1;s-N1 and ALEXX. It thus appears unlikely that the phenotype of <italic>Gnas</italic>xl knockout mice is due solely to XL&#x003b1;s deficiency. Nonetheless, a similar phenotype is present in mice with paternal <italic>Gnas</italic> exon 2 disruption [<xref ref-type="bibr" rid="R77">77</xref>-<xref ref-type="bibr" rid="R79">79</xref>] and in mice with a paternally inherited missense mutation in exon 6 [<xref ref-type="bibr" rid="R80">80</xref>,<xref ref-type="bibr" rid="R81"> 81</xref>], thereby ruling out the involvement of ALEX, XL&#x003b1;s-N1, and XXL&#x003b1;s-N1 deficiency in the phenotypes of the <italic>Gnas</italic>xl knockout mice. Thus, it is more likely that the deficiency of XL&#x003b1;s and/or XXL&#x003b1;s underlies the findings observed in the latter mouse model, although this conclusion needs to be verified through further investigation. It is important to note that the phenotype of the <italic>Gnas</italic>xl knockout mice differs, by and large, from the phenotype of mice heterozygous for disruption of <italic>Gnas</italic> exon 1, in which Gs&#x003b1;, but not XL&#x003b1;s, is ablated [<xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R82"> 82</xref>]. In fact, <italic>Gnas</italic>xl knockout mice demonstrate slightly elevated basal and isoproterenol stimulated cAMP levels in brown adipose tissue at birth [<xref ref-type="bibr" rid="R67">67</xref>]. These findings suggest that XL&#x003b1;s has a role distinct from the role of Gs&#x003b1; in mammals, and that it may oppose, at least in certain tissues, the actions of Gs&#x003b1;.</p><p>Findings that are reminiscent of those observed in <italic>Gnas</italic>xl knockout mice and the mice with paternal <italic>Gnas</italic> exon 2 disruption have been reported in two unrelated children with large paternal deletions of chromosome 20q13.3 that comprise the <italic>GNAS</italic> locus [<xref ref-type="bibr" rid="R83">83</xref>]. These findings included perinatal growth retardation, intractable feeding difficulties, and loss of subcutaneous adiposity, as well as dysmorphic facial features. Because the deletion involved, in each case, the entire <italic>GNAS</italic> locus, it is possible that the phenotype reflects, at least partially, the deficiency of Gs&#x003b1; and/or the other paternally expressed <italic>GNAS</italic> products (see below).</p></sec><sec><title>The A/B Transcript</title><p>About 2.5 kb upstream of the Gs&#x003b1; promoter lies another promoter that drives the nearly ubiquitous expression of another transcript termed A/B (also termed 1A and 1&#x02019;) [<xref ref-type="bibr" rid="R84">84</xref>-<xref ref-type="bibr" rid="R86">86</xref>]. The A/B promoter, despite being in close proximity to the Gs&#x003b1; promoter, reside within a DMR, where the maternal allele is methylated and repressed, while the paternal allele is non-methylated and active (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). The first exon of the A/B transcript, as in NESP55 and XL&#x003b1;s, splices onto Gs&#x003b1; exons 2-13. However, exon A/B does not contain an in-frame translation initiation codon, and as supported by evidence from <italic>in vitro</italic> translation assays [<xref ref-type="bibr" rid="R86">86</xref>], translation can be initiated by an in-frame AUG located in exon 2, leading, presumably, to a variant of Gs&#x003b1; that has a truncated N-terminus. Transfection of COS cells with A/B cDNA results in the expression of a protein that localizes to the plasma membrane [<xref ref-type="bibr" rid="R86">86</xref>]. Based on these features, it is conceivable that the A/B protein interacts with adenylyl cyclase and may, therefore, exert a dominant negative effect on Gs&#x003b1; actions. This possibility remains to be investigated.</p><p>On the other hand, it appears more likely that the A/B transcript is non-coding, as the existence of an endogenous A/B protein is not supported by experimental evidence. Furthermore, similar to other non-coding RNA molecules in the genome, the A/B transcript and/or the exon A/B DMR has an important role in regulating gene expression from <italic>GNAS</italic>. Unlike the DMRs comprising the promoters of NESP55 and XL&#x003b1;s, the exon A/B DMR has been shown to be a germ-line imprint mark [<xref ref-type="bibr" rid="R85">85</xref>]. It has also been shown that this DMR is associated with allele-specific differences in histone modifications consistent with an active paternal (histone acetylation and histone-3 Lys<sup>4</sup> methylation) and an inactive maternal (histone-3 Lys<sup>9</sup> metyhlation) promoter [<xref ref-type="bibr" rid="R42">42</xref>,<xref ref-type="bibr" rid="R87"> 87</xref>]. In addition, paternal ablation of the A/B DMR results in derepression of the Gs&#x003b1; transcript in those tissues where paternal Gs&#x003b1; expression is normally silenced, such as the renal cortex [<xref ref-type="bibr" rid="R81">81</xref>,<xref ref-type="bibr" rid="R88"> 88</xref>]. Thus, it appears that the non-methylated A/B DMR and/or active A/B transcription is necessary for the tissue-specific paternal silencing of Gs&#x003b1;. Consistent with this finding, maternal exon A/B is unmethylated and the maternal A/B promoter is derepressed in patients with pseudohypoparathyroidism type-Ib [<xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R89"> 89</xref>,<xref ref-type="bibr" rid="R90"> 90</xref>], who are thought to have a lack of Gs&#x003b1; expression in the proximal tubule due to silencing of the maternal Gs&#x003b1; promoter (in addition to the silencing of the paternal Gs&#x003b1; promoter that occurs normally in the same tissue; see below for further discussion).</p><p>The mechanisms underlying the role of A/B in the tissue-specific silencing of paternal Gs&#x003b1; expression are not well understood. Considering that the A/B transcription takes place more broadly than does paternal Gs&#x003b1; silencing, a mechanism that involves simple competition between the promoters of these two transcripts is unlikely. On the other hand, a plausible hypothesis involves a mechanism whereby the paternal A/B DMR binds either a repressor that directly silences the Gs&#x003b1; promoter or an insulator that prevents the effects of an upstream enhancer on the Gs&#x003b1; promoter. A mechanism similar to the latter has been demonstrated for the Igf2-H19 locus, in which methylation-sensitive binding of CTCF hinders Igf2 enhancer activity [<xref ref-type="bibr" rid="R91">91</xref>,<xref ref-type="bibr" rid="R92"> 92</xref>]. To address these possibilities, it may be necessary to generate and study additional mouse models in which A/B transcript is disrupted without the deletion of its promoter region.</p></sec><sec><title>The <italic>GNAS</italic> Antisense Transcript</title><p>A promoter located immediately upstream of the XL&#x003b1;s promoter drives expression of an antisense transcript, which extends past the exon(s) encoding NESP55 [<xref ref-type="bibr" rid="R93">93</xref>,<xref ref-type="bibr" rid="R94"> 94</xref>] (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). In mice, the mature antisense transcript (termed Nespas or <italic>Gnas</italic>as) encompasses both Nesp55 exons 1 and 2 and the intervening intron [<xref ref-type="bibr" rid="R94">94</xref>], while in humans, it has no overlap with exon NESP55 [<xref ref-type="bibr" rid="R93">93</xref>]. There are at least five distinct exons that form the human <italic>GNAS</italic> antisense transcript, but alternative splicing results in at least six variants. The largest open reading frame is predicted to encode a polypeptide of 97 amino acids that share no homology to known proteins [<xref ref-type="bibr" rid="R93">93</xref>]. Taken together these features suggest that the antisense transcript is non-coding. Indeed, similar to the promoter of A/B, the promoter of the <italic>GNAS</italic> antisense promoter resides in a DMR and is active exclusively on the paternal allele [<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R93"> 93</xref>,<xref ref-type="bibr" rid="R94"> 94</xref>]; however, the antisense transcript shows biallelic expression in the adrenal and testes [<xref ref-type="bibr" rid="R65">65</xref>]. Consistent with allele-specific expression, the paternal antisense promoter is associated with acetylated histone and histone-3 Lys<sup>4</sup> methylation, while the maternal promoter lacks histone acetylation and carries histone-3 Lys<sup>9</sup> methylation [<xref ref-type="bibr" rid="R87">87</xref>]. Furthermore, studies in mice have shown that the maternal methylation at the antisense promoter is present even in the oocytes and, therefore, represents a germ-line imprint mark [<xref ref-type="bibr" rid="R95">95</xref>].</p><p>Paternal deletion of the antisense promoter in mice results in derepression of Nesp55 <italic>in cis</italic>, thereby leading to biallelic expression of the latter [<xref ref-type="bibr" rid="R96">96</xref>]. This finding indicates that at least one of the roles of the antisense transcript is to silence the paternal Nesp55 promoter. However, the effect of the deletion of the antisense promoter is not limited to Nesp55 expression. First, the deleted region evidently comprises an enhancer of the XL&#x003b1;s promoter, resulting in a dramatic reduction in XL&#x003b1;s expression and, thus, a phenotype similar to that observed in <italic>Gnas</italic>xl knockout mice. Second, mice with the paternal deletion exhibit a modest decrease in A/B expression combined with an increase in the methylation of the A/B promoter. Third, in those tissues where Gs&#x003b1; is normally silenced from the paternal allele, the diminished A/B expression is associated with an increase in Gs&#x003b1; expression <italic>in cis</italic>, i.e. the tissue specific Gs&#x003b1; imprinting is relaxed. These findings clearly demonstrate the importance of the antisense transcript in the regulation of imprinted gene expression from the <italic>GNAS</italic> locus. Nonetheless, what causes the reduction of paternal A/B expression remains unclear. Is it the derepression of Nesp55, the reduction of XL&#x003b1;s expression, or the deletion of the genomic region containing the antisense promoter?</p></sec></sec><sec><title>HUMAN DISEASES ASSOCIATED WITH <italic>GNAS</italic> MUTATIONS</title><p>Consistent with the pivotal role of Gs&#x003b1; in multiple biological responses, mutations that affect the activity or expression of Gs&#x003b1; lead to human disease. However, there are no disorders caused by inactivation of both Gs&#x003b1; alleles, i.e. homozygous inactivating Gs&#x003b1; mutations, and this is consistent with the early embryonic lethality observed in mice with homozygous disruption of either <italic>Gnas</italic> exon 2 or <italic>Gnas</italic> exon 1 [<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41"> 41</xref>,<xref ref-type="bibr" rid="R82"> 82</xref>]. Thus, complete loss of Gs&#x003b1; activity is not compatible with life. Moreover, there are mutations that cause constitutive Gs&#x003b1; activity, but these are virtually never inherited and are of somatic origin, indicating that universal Gs&#x003b1; overactivity is embryonic lethal, as well.</p><sec><title>Endocrine Adenomas and other Tumors</title><p>Many hormones bind Gs&#x003b1;-coupled receptors in order to activate their endocrine glands for proliferation, differentiation, and hormone secretion. Accordingly, mutations that cause constitutive Gs&#x003b1; activity are found in various functionally active endocrine adenomas, including those that originate from pituitary somatotrophs. In about 40% of patients with growth hormone secreting pituitary adenomas, constitutively activating Gs&#x003b1; missense mutations at either Arg<sup>201</sup> or Gln<sup>227</sup> have been identified in DNA from the tumor tissue, but not in DNA from peripheral blood [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R97"> 97</xref>]. Since these mutant Gs&#x003b1; forms are identified in tumors and are present in one of the Gs&#x003b1; alleles only, they are referred to as the <italic>gsp</italic> oncogene [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R97"> 97</xref>]. Other endocrine tumors also bare the <italic>gsp</italic> oncogene, including corticotroph, thyroid, parathyroid, and adrenocortical tumors, but their frequency in the patient population appears to be low based on many studies (reviewed in [<xref ref-type="bibr" rid="R98">98</xref>]). Some studies have recently identified the <italic>gsp</italic> oncogene in ovarian granulosa cell tumors and testicular stromal Leydig cell tumors as a possible cause of tumorigenesis and as a possible prognostic marker [<xref ref-type="bibr" rid="R99">99</xref>,<xref ref-type="bibr" rid="R100"> 100</xref>]. In a more recent study, 5 of 30 patients with clear cell renal carcinoma have been shown to carry constitutively activating Gs&#x003b1; mutations in the tumor tissue [<xref ref-type="bibr" rid="R101">101</xref>]. Hence, the <italic>gsp</italic> oncogene can be present in a wide variety of tumors that mostly, but not exclusively, involve classic endocrine tissues. Data from transgenic mouse models and cell culture assays have shown that constitutive Gs&#x003b1; activity can lead to hyperplasia and increased hormone secretion in endocrine cells [<xref ref-type="bibr" rid="R102">102</xref>,<xref ref-type="bibr" rid="R103"> 103</xref>]. However, although a recent study implicates sustained activation of extracellular signal-regulated kinase in increased hormone secretion [<xref ref-type="bibr" rid="R104">104</xref>], the signaling pathways downstream of the <italic>gsp</italic> oncogene currently remain incompletely understood.</p></sec><sec><title>McCune-Albright Syndrome</title><p>This syndrome, independently described by McCune [<xref ref-type="bibr" rid="R105">105</xref>] and Albright <italic>et al</italic>. [<xref ref-type="bibr" rid="R106">106</xref>], is characterized by a triad of sexual precocity, fibrous dysplasia of bone, and hyperpigmented skin lesions termed caf&#x000e9;-au-lait spots. Patients with the McCune-Albright syndrome (MAS) are mosaic for constitutively activating Gs&#x003b1; mutations that occur during early embryonic development [<xref ref-type="bibr" rid="R107">107</xref>-<xref ref-type="bibr" rid="R109">109</xref>]. This is consistent with the observation that MAS occurs sporadically and is never transmitted to the next generation. All identified mutations are at residue Arg<sup>201</sup> (Cys or His), suggesting that changes in residue Gln<sup>227</sup> may result in higher constitutive activity and are, therefore, less viable. Because of the mosaicism, patients with MAS show significant variation in their clinical presentation. In general, the abnormalities involve bone, skin, and endocrine organs. Fibrous dysplastic bone lesions are usually found in multiple bones. It is important to note that some patients with the constitutively activating Gs&#x003b1; mutations present with fibrous dysplasia alone, affecting either a single bone or multiple bones. In patients with isolated fibrous dysplasia, histological changes appear to be indistinguishable form those seen in the context of MAS [<xref ref-type="bibr" rid="R110">110</xref>,<xref ref-type="bibr" rid="R111"> 111</xref>]. As in patients with MAS, nearly all isolated cases of fibrous dysplasia are associated with <italic>GNAS</italic> mutations at Arg<sup>201</sup>; however, a study using a mutation-specific restriction enzyme digest assay has recently identified three Gln<sup>227</sup> (to Leu) mutations among a total of 56 samples [<xref ref-type="bibr" rid="R112">112</xref>]. The skin lesions, which typically have irregular borders, can be single or multiple light brown hyperpigmented areas arranged in segmental patterns that follow the developmental lines of Blaschko [<xref ref-type="bibr" rid="R106">106</xref>,<xref ref-type="bibr" rid="R109"> 109</xref>]. Endocrine abnormalities, in addition to precocious puberty, can be summarized as hyperplasia and increased function of many different glands, including thyroid, adrenal, and pituitary [<xref ref-type="bibr" rid="R113">113</xref>-<xref ref-type="bibr" rid="R115">115</xref>]. Some patients with MAS also exhibit urinary phosphate wasting, hypophosphatemia, and bone mineralization defects observed as rickets or osteomalacia [<xref ref-type="bibr" rid="R113">113</xref>,<xref ref-type="bibr" rid="R114"> 114</xref>]. While the latter findings are consistent with the role of Gs&#x003b1; in mediating the phosphaturic actions of parathyroid hormone in the renal proximal tubule, recent data shows that serum phosphate in MAS patients is negatively correlated with the level of fibroblast growth factor-23 [<xref ref-type="bibr" rid="R116">116</xref>-<xref ref-type="bibr" rid="R118">118</xref>], suggesting that the elevation of this phosphaturic factor is responsible, at least partly, for the hypophosphatemia observed in these patients. In addition to the various endocrine defects discussed above, there are rare reports of non-endocrine abnormalities associated with MAS, including liver and cardiac abnormalities, and neurological defects. The endocrine and non-endocrine findings in MAS have been reviewed elsewhere in greater detail [<xref ref-type="bibr" rid="R98">98</xref>].</p></sec><sec><title>Pseudohypoparathyroidism Type-Ia, Pseudopseudohypoparathyroidism, and Progressive Osseous Heteroplasia</title><p>Fist described by Albright and colleagues [<xref ref-type="bibr" rid="R119">119</xref>], Pseudohypoparathyroidism (PHP) refers to end-organ resistance to multiple hormones that primarily involves the actions of parathyroid hormone. PTH exerts its actions in bone and kidney through the PTH/parathyroid hormone-related peptide receptor (PTHR1), which couples to Gs and, less effectively, to Gq [<xref ref-type="bibr" rid="R120">120</xref>,<xref ref-type="bibr" rid="R121"> 121</xref>]. PTH increases bone turnover, leading to mobilization of calcium and phosphate from bone [<xref ref-type="bibr" rid="R122">122</xref>,<xref ref-type="bibr" rid="R123"> 123</xref>]. In the proximal renal tubule, it induces the synthesis of 1,25-dihydroxyvitamin D and inhibits phosphate reabsorption from the glomerular filtrate, while in the distal renal tubule, it enhances the absorption of calcium mediated <italic>via </italic>transcellular mechanisms. Exogenous administration of biologically active PTH, used previously as a diagnostic test [<xref ref-type="bibr" rid="R124">124</xref>], results in a blunted excretion of urinary phosphate in both PHP type-I and PHP type-II, but this defect is accompanied by blunted nephrogenous cAMP production in PHP type-I only; the PTH-induced generation of nephrogenous cAMP is normal in PHP type-II [<xref ref-type="bibr" rid="R119">119</xref>,<xref ref-type="bibr" rid="R125"> 125</xref>]. Clinically, PHP-I is far more frequent than PHP-II, for which underlying molecular defects are not well understood. On the other hand, significant advances have been recently made regarding the molecular pathology underlying PHP-I.</p><p>Some patients with PHP-I display distinctive physical features collectively termed Albright&#x02019;s hereditary osteodystrophy [<xref ref-type="bibr" rid="R119">119</xref>]. These features include obesity, short stature, ectopic ossification, brachydactyly, and mild mental retardation, although there is significant patient-to-patient variation in the range and severity of these features. The presence of both PTH-resistance and AHO defines patients with PHP type-Ia. Gs&#x003b1; mRNA and protein levels are reduced to half in easily accessible tissues from these patients [<xref ref-type="bibr" rid="R126">126</xref>-<xref ref-type="bibr" rid="R128">128</xref>]. This defect results from heterozygous inactivating mutations within one of the thirteen Gs&#x003b1; coding <italic>GNAS</italic> exons [<xref ref-type="bibr" rid="R129">129</xref>,<xref ref-type="bibr" rid="R130"> 130</xref>]. Scattered throughout the gene, various different types of mutations, such as insertions, deletions, and missense and nonsense changes, have been identified, which is consistent with their inactivating nature. An extensive list of the mutations associated with this disorder can be found under OMIM entry #139320 at <uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</uri>.</p><p>Because Gs&#x003b1; is not exclusive for PTH signaling, PHP-Ia patients also show resistance to some other hormones whose actions depend on Gs&#x003b1; signaling, including thyroid stimulating hormone (TSH), gonadotropins, and growth hormone releasing hormone (GHRH) [<xref ref-type="bibr" rid="R131">131</xref>-<xref ref-type="bibr" rid="R135">135</xref>]. It is worth noting that not all hormone actions that rely on Gs&#x003b1; are impaired in PHP-Ia. For example, there is no resistance to vasopressin [<xref ref-type="bibr" rid="R136">136</xref>,<xref ref-type="bibr" rid="R137"> 137</xref>] or to hormones in the hypothalomo-pituitary-adrenal axis [<xref ref-type="bibr" rid="R134">134</xref>,<xref ref-type="bibr" rid="R136"> 136</xref>,<xref ref-type="bibr" rid="R138"> 138</xref>].</p><p>Inactivating Gs&#x003b1; mutations found in PHP-Ia patients are also present in patients who lack hormone resistance but present with AHO features, a condition referred to as pseudopseudohypoparathyroidism (PPHP) [<xref ref-type="bibr" rid="R139">139</xref>]. Mutations in patients with PPHP are often identical to those in PHP-Ia patients. In fact, both disorders typically co-exist in the same kindred [<xref ref-type="bibr" rid="R129">129</xref>,<xref ref-type="bibr" rid="R140"> 140</xref>], with the gender of the affected parent determining whether the offspring will have PHP-Ia or PPHP: maternal inheritance leads to PHP-Ia, whereas paternal inheritance leads to PPHP [<xref ref-type="bibr" rid="R141">141</xref>,<xref ref-type="bibr" rid="R142"> 142</xref>]. Thus, hormone resistance (PHP-Ia) is inherited only from female obligate carriers, a mode of inheritance that is consistent with the predominantly maternal expression of Gs&#x003b1; in certain tissues. It is important to note that the repertoire of hormone resistance in PHP-Ia correlates well with the tissues in which maternal, monoallelic Gs&#x003b1; expression takes place, underscoring the significance of Gs&#x003b1; imprinting in the pathogenesis of PHP-Ia.</p><p>AHO features are present in both PHP-Ia and PPHP patients, and therefore, the molecular mechanisms underlying AHO presumably entail Gs&#x003b1; haploinsufficiency rather than imprinting. Gs&#x003b1; haploinsufficiency has been demonstrated in the growth plate of mice chimeric for wild-type cells and cells heterozygous for disruption of either the maternal or the paternal <italic>Gnas</italic> exon 2 [<xref ref-type="bibr" rid="R143">143</xref>]. In the chimeric setting, the mutant chondrocytes undergo hypertrophic differentiation sooner than wild-type chondrocytes, and because this finding is qualitatively similar to (albeit far less severe than) that observed in chondrocytes with homozygous Gs&#x003b1; ablation under the same conditions, it indicates Gs&#x003b1; haploinsufficiency. While this study strongly suggests that the short stature and the brachydactyly seen in patients with AHO reflect, at least in part, Gs&#x003b1; haploinsufficiency in the growth plate, some features of AHO may still involve Gs&#x003b1; imprinting in the pathogenesis. For example, a recent study has clearly shown that obesity is more prominent in PHP-Ia patients than PPHP patients [<xref ref-type="bibr" rid="R144">144</xref>]. Thus, it appears that Gs&#x003b1; may be imprinted in more tissues than currently recognized, such as in parts of the brain that controls satiety and body weight. It is also possible that disruption of other imprinted <italic>GNAS</italic> gene products contribute to the pathogenesis of AHO. Supporting this hypothesis, chondrocytes with paternal <italic>Gnas</italic> exon 2 disruption exhibit a slightly, but significantly, higher degree of Gs&#x003b1; haploinsufficiency than chondrocytes with maternal <italic>Gnas</italic> exon 2 disruption [<xref ref-type="bibr" rid="R143">143</xref>]. More detailed characterization of the different AHO features between patients with paternally and maternally inherited Gs&#x003b1; mutations are likely to provide further insights into the understanding of the mechanisms underlying AHO.</p><p>Progressive osseous heteroplasia (POH) describes a severe, debilitating disease characterized by ectopic intramembranous bone formation that affects not only the subcutis, but also the skeletal muscle and the deep connective tissue [<xref ref-type="bibr" rid="R145">145</xref>]. Heterozygous inactivation mutations within the Gs&#x003b1; coding <italic>GNAS</italic> exons have also been identified in patients with POH. In fact, some of those mutations are identical to those found in patients with PHP-Ia or PPHP [<xref ref-type="bibr" rid="R145">145</xref>-<xref ref-type="bibr" rid="R147">147</xref>]. It is therefore possible that POH is an extreme manifestation of the ectopic bone formation of AHO that normally involves the subcutaneous tissue. However, POH is rarely accompanied with any AHO features or hormone resistance [<xref ref-type="bibr" rid="R146">146</xref>,<xref ref-type="bibr" rid="R148"> 148</xref>]. Furthermore, in many kindreds, it has been shown that the disease develops only after paternal inheritance [<xref ref-type="bibr" rid="R147">147</xref>], suggesting that genomic imprinting also plays a role in the pathogenesis of POH. Because this disorder is paternally inherited, deficiency of <italic>GNAS</italic> products that show paternal specific expression and share exons with Gs&#x003b1;, such as XL&#x003b1;s, could contribute to ectopic bone formation. Consistent with this hypothesis, no mutations in exon 1 has thus far been reported in cases with isolated POH [<xref ref-type="bibr" rid="R147">147</xref>,<xref ref-type="bibr" rid="R149"> 149</xref>,<xref ref-type="bibr" rid="R150"> 150</xref>]. However, the roles of XL&#x003b1;s and other imprinted <italic>GNAS</italic> products in POH remain currently undefined.</p></sec><sec><title>PHP Type-Ib</title><p>Some patients with PTH-resistance lack AHO and any additional hormone resistance, defining the typical features of PHP type-Ib (PHP-Ib). Recent studies have demonstrated that some PHP-Ib patients also have mild TSH resistance in addition to PTH resistance [<xref ref-type="bibr" rid="R89">89</xref>,<xref ref-type="bibr" rid="R90"> 90</xref>,<xref ref-type="bibr" rid="R151"> 151</xref>]. Furthermore, a single study described several patients who showed both the epigenetic defects characteristic of PHP-Ib (see below) and mild features of AHO [<xref ref-type="bibr" rid="R152">152</xref>], suggesting more variation in the phenotype. Unlike in PHP-Ia, Gs&#x003b1; activity is typically normal in easily accessible cells from these patients, thus excluding mutations within Gs&#x003b1; coding <italic>GNAS</italic> exons [<xref ref-type="bibr" rid="R131">131</xref>,<xref ref-type="bibr" rid="R153"> 153</xref>]. Nonetheless, in three related patients with an apparent diagnosis of PHP-Ib an in-frame, tri-nucleotide deletion has been identified within exon 13 [<xref ref-type="bibr" rid="R154">154</xref>]. Expressed in HEK293 cells, an embryonic kidney derived cell line, this Gs&#x003b1; mutant was shown to affect the signaling of PTH, but not of TSH, LH, or isoproterenol, thus explaining the isolated PTH resistance. The selective effect of this mutation on PTH signaling, however, could not be verified in a subsequent study [<xref ref-type="bibr" rid="R70">70</xref>], and it is possible that the discrepancy between the two studies stems from the use of different cell types and/or assays; the second study used mouse embryonic fibroblasts <italic>null</italic> for endogenous Gs&#x003b1; [<xref ref-type="bibr" rid="R70">70</xref>,<xref ref-type="bibr" rid="R71"> 71</xref>]. Alternatively, the three patients may have PHP-Ia, consistent with the observation that two of them exhibited advanced bone age [<xref ref-type="bibr" rid="R154">154</xref>], which is a typical sign of AHO. Since the urinary cAMP response to exogenously administered PTH is blunted in PHP-Ib patients [<xref ref-type="bibr" rid="R131">131</xref>], defects in the gene encoding PTHR1 seemed like a good candidate at the time. However, several studies have ruled out this possibility [<xref ref-type="bibr" rid="R153">153</xref>,<xref ref-type="bibr" rid="R155"> 155</xref>-<xref ref-type="bibr" rid="R157">157</xref>].</p><p>PHP-Ib is often sporadic, but a number of familial cases have also been described. A careful analysis of these pedigrees has revealed that the PTH resistance in PHP-Ib develops only if the genetic defect is inherited from a female carrier [<xref ref-type="bibr" rid="R158">158</xref>], i.e. the mode of inheritance is identical to that observed for hormone resistance in PHP-Ia. Genetic linkage studies using some of these kindreds have mapped the genetic defect to a region of chromosome 20q that comprises the <italic>GNAS</italic> locus [<xref ref-type="bibr" rid="R158">158</xref>,<xref ref-type="bibr" rid="R159"> 159</xref>]. Moreover, most PHP-Ib patients exhibit <italic>GNAS</italic> imprinting defects [<xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R89"> 89</xref>]. Although these defects involve multiple <italic>GNAS</italic> DMRs in some cases, the most consistent defect is a loss of imprinting at the A/B DMR, i.e. loss of methylation at the A/B promoter and exon combined with biallelic A/B expression, which appears to be an isolated defect in most familial PHP-Ib cases [<xref ref-type="bibr" rid="R89">89</xref>,<xref ref-type="bibr" rid="R160"> 160</xref>]. Based on these findings, the genetic mutation responsible for PHP-Ib is thought to disrupt an imprinting regulatory element of <italic>GNAS</italic>. The most frequent mutation, identified thus far in more than 30 unrelated kindreds, is a unique 3-kb microdeletion located about 220 kb upstream of exon A/B [<xref ref-type="bibr" rid="R160">160</xref>-<xref ref-type="bibr" rid="R163">163</xref>] (Fig. <bold><xref ref-type="fig" rid="F4">4</xref></bold>). Flanked by two 391-bp repeats, the 3-kb microdeletion removes exons 4-6 of <italic>STX16</italic>, the gene encoding syntaxin-16. The second mutation is a 4.4-kb microdeletion that overlaps with the former and removes <italic>STX16</italic> exons 2-4; this mutation, unlike the 3-kb microdeletion, has been found in only one kindred thus far [<xref ref-type="bibr" rid="R164">164</xref>]. These mutations cause disease only after maternal inheritance, and each affected individual carrying either of these mutations displays an isolated loss of exon A/B imprinting, thereby indicating that the mutations disrupt a cis-acting element that controls imprinting at the exon A/B DMR [<xref ref-type="bibr" rid="R160">160</xref>,<xref ref-type="bibr" rid="R164"> 164</xref>]. This element may lie within the 1.3-kb region where the two deletions overlap. The overlapping region comprises exon 4, which is evolutionarily conserved and lies within a small CpG-rich region that lacks differential methylation [<xref ref-type="bibr" rid="R160">160</xref>]. It is also possible that the identified deletions independently disrupt a large control element that spans <italic>STX16</italic>. On the other hand, disruption of <italic>STX16</italic> is not considered to be involved in the pathogenesis of PHP-Ib, because there is no evidence that this gene is imprinted [<xref ref-type="bibr" rid="R160">160</xref>,<xref ref-type="bibr" rid="R164"> 164</xref>].</p><p>All sporadic and some familial PHP-Ib cases show epigenetic defects at one or more <italic>GNAS</italic> DMRs in addition to the exon A/B DMR [<xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R89"> 89</xref>]. These defects often consist of a loss of imprinting at exon A/B, exon XL, and the promoter of the antisense transcript and a gain of imprinting at exon NESP55. Two unrelated familial cases with such <italic>GNAS</italic> imprinting abnormalities have been shown to carry maternally inherited deletions of the entire NESP55 DMR including exons 3 and 4 of the antisense transcript [<xref ref-type="bibr" rid="R165">165</xref>], revealing the putative location of another control element required for the imprinting of the entire maternal <italic>GNAS</italic> allele (Fig. <bold><xref ref-type="fig" rid="F4">4</xref></bold>). The presence of similarly large deletions at the NESP55 DMR has been excluded in a number of sporadic PHP-Ib cases [<xref ref-type="bibr" rid="R165">165</xref>].</p><p>The broad <italic>GNAS</italic> epigenetic defects seen in the sporadic cases are often such that the maternal allele has attained a paternal epigenotype. Accordingly, a sporadic PHP-Ib case has been shown to have paternal uniparental isodisomy of the entire chromosome 20q (patUPD20q) [<xref ref-type="bibr" rid="R90">90</xref>]. Leading to the diagnosis were PTH-resistance and mild TSH resistance in the absence of typical AHO findings, although the patient had additional abnormalities, including developmental delay and craniosynostosis, which may have resulted from either disrupted expression of other imprinted genes or from unmasking of recessive defects present on paternal chromosome 20q. Hence, patUPD20q is a cause of sporadic PHP-Ib, and it is possible that interstitial paternal UPDs in this region could lead to PHP-Ib as a more common cause of this disorder in the sporadic cases. It has also been suggested that some cases of sporadic PHP-Ib is caused by stochastic defects in the imprinting process [<xref ref-type="bibr" rid="R162">162</xref>]. In either case, the offspring of affected females would be predicted to have normal <italic>GNAS</italic> imprinting and normal proximal tubular PTH responsiveness even if they inherit the disease-associate allele.</p><p>Sporadic PHP-Ib cases typically differ from familial PHP-Ib cases in the nature of the <italic>GNAS</italic> epigenetic defects they exhibit, yet evaluation of many cases with these PHP forms indicates that the divergence in the epigenetic features do not directly translate into differences in clinical presentation. The age of onset and the severity of hypocalcemia and hyperphosphatemia that result from PTH resistance appear to be similar in sporadic and familial cases [<xref ref-type="bibr" rid="R62">62</xref>]. As explained above, Gs&#x003b1; expression is also predominantly maternal in the pituitary somatotrophs [<xref ref-type="bibr" rid="R43">43</xref>]; however, growth hormone deficiency and short stature are not typical clinical features of PHP-Ib. It is possible that the epigenetic defects do not affect Gs&#x003b1; expression in this tissue, thereby allowing unimpaired GHRH signaling. This could suggest that the mechanisms underlying Gs&#x003b1; imprinting are different between the pituitary and the proximal tubule. Alternatively, GHRH resistance may be present in patients with PHP-Ib, but it may be too mild to become clinically manifest. This is similar to the TSH resistance in PHP-Ib, which can be absent in many PHP-Ib patients, is milder than in PHP-Ia, and can be accounted for by the partial imprinting of Gs&#x003b1; in the thyroid [<xref ref-type="bibr" rid="R151">151</xref>]. Mild short-stature has been recently reported in some patients who show PTH-resistance and <italic>GNAS</italic> imprinting defects [<xref ref-type="bibr" rid="R152">152</xref>], consistent with GHRH resistance and resultant growth hormone deficiency. Nevertheless, it remains unknown whether patients with PHP-Ib have reduced Gs&#x003b1; expression in the pituitary and whether they display GHRH resistance.</p><p>The common defect in nearly all PHP-Ib cases is the loss of <italic>GNAS</italic> exon A/B imprinting. In fact, this epigenetic defect is necessary for the development of PTH resistance, as documented in a PHP-Ib kindred in whom some individuals lacked both loss of A/B imprinting and PTH resistance despite maternally inheriting the disease-associated haplotype on 20q [<xref ref-type="bibr" rid="R166">166</xref>]. The loss of A/B imprinting on the maternal allele is predicted to silence, <italic>in cis</italic>, Gs&#x003b1; transcription in the proximal tubule. Therefore, methylation of exon A/B DMR and/or the repression of A/B transcription appear to be required for maternal Gs&#x003b1; expression in this and, probably, other tissues, such as the thyroid gland. Supporting this notion, ablation of the paternal exon A/B region derepresses Gs&#x003b1; <italic>in cis</italic> in tissues where this signaling protein is paternally silenced [<xref ref-type="bibr" rid="R81">81</xref>,<xref ref-type="bibr" rid="R88"> 88</xref>] and, furthermore, rescues the PTH resistance phenotype observed in mice with a point mutation in maternal <italic>Gnas</italic> exon 6 [<xref ref-type="bibr" rid="R80">80</xref>,<xref ref-type="bibr" rid="R81"> 81</xref>].</p></sec></sec><sec><title>ANIMAL MODELS OF THE <italic>GNAS</italic>-RELATED DISEASES</title><sec><title>PHP-Ia/PPHP</title><p>Before the evidence that several different <italic>GNAS</italic> transcripts, in addition to Gs&#x003b1;, utilize exon 2, a mouse model of PHP-Ia was generated by targeted disruption of this exon [<xref ref-type="bibr" rid="R40">40</xref>]. Homozygous disruption of exon 2 results in early embryonic lethality. Furthermore, paternal heterozygous disruption leads to lethality within the first 24 h after birth, and maternal heterozygous disruption results in death within the first three weeks. Surviving animals are fertile and appear to have normal life spans. As explained above, mice with paternal disruption of <italic>Gnas</italic> exon 2 have severe defects that are similar to those seen in mice with paternal disruption of <italic>Gnas</italic>xl [<xref ref-type="bibr" rid="R67">67</xref>], including reduced adiposity, which is not seen in patients with paternally inherited inactivating Gs&#x003b1; mutations (PPHP); these patients are typically overweight. On the other hand, both the maternal and the paternal <italic>Gnas</italic> exon 2 knockout mice appear smaller than their littermates, reminiscent of the short stature observed in patients with AHO. Furthermore, the exon 2 knockout mice prove to be a good model of PTH resistance. Reflecting the tissue-specific silencing of paternal Gs&#x003b1; in the proximal tubule, PTH-resistance, characterized by hypocalcemia, hyperphosphatemia, and elevated serum PTH, is present only after maternal inheritance of the disrupted allele [<xref ref-type="bibr" rid="R40">40</xref>]. In addition, PTH stimulation of proximal tubule extracts from mice with the maternal disruption, but not with the paternal disruption, fail to increase cAMP levels. Similar to the observations in PHP-Ia patients, the urine concentrating ability of the kidney in response to vasopressin is unimpaired in both the maternal and the paternal knockouts. Hence, although the findings resulted from the disruption of exon 2 are rather complicated due to the use of this exon by not only Gs&#x003b1; but also several other <italic>GNAS</italic> products (particularly XL&#x003b1;s), this animal model is able to phenocopy PHP-Ia to a significant extent.</p><p>Chen <italic>et al. </italic>[<xref ref-type="bibr" rid="R82">82</xref>] and Germain-Lee <italic>et al. </italic>[<xref ref-type="bibr" rid="R41">41</xref>] have independently generated another model of PHP-Ia through targeted disruption of <italic>Gnas</italic> exon 1. In addition to early embryonic lethality observed upon homozygous inheritance of exon 1 disruption, even the heterozygous disruption is associated with some pre-weaning mortality regardless of the parental origin. While this finding is not observed in families with PHP-Ia/PPHP, the overall phenotype of mice heterozygous for maternal disruption of <italic>Gnas</italic> exon 1 resembles that of PHP-Ia remarkably. Mice with maternal disruption of exon 1 develop biochemical features consistent with PTH resistance [<xref ref-type="bibr" rid="R41">41</xref>]. In humans with inactivating Gs&#x003b1; mutations it is accepted that obesity develops regardless of the parent-of-origin of the introduced mutation, but recent evidence indicates that patients with PHP-Ia exhibit more prominent obesity than patients with PPHP [<xref ref-type="bibr" rid="R144">144</xref>]. Consistent with this recent observation, mice with the maternal <italic>Gnas</italic> exon 1 disruption is more obese than the paternal disruption [<xref ref-type="bibr" rid="R82">82</xref>]. In contrast to these similarities between the mouse models of exon 1 ablation and PHP-Ia/PPHP, the serum PTH level seems to be moderately elevated in mice with paternal <italic>Gnas</italic> exon 1 ablation, suggesting the presence of PTH-resistance [<xref ref-type="bibr" rid="R41">41</xref>]. This finding is not observed in mice with paternal ablation of exon 2 and may therefore reflect the preservation of <italic>Gnas</italic> transcripts that use exon 2, such as XL&#x003b1;s. Although this conclusion is contrary to the evidence that XL&#x003b1;s can mimic Gs&#x003b1; [<xref ref-type="bibr" rid="R70">70</xref>,<xref ref-type="bibr" rid="R71"> 71</xref>,<xref ref-type="bibr" rid="R143"> 143</xref>], it correlates well with the notion that Gs&#x003b1; and XL&#x003b1;s, which are oppositely imprinted in certain tissues, mediate opposing actions [<xref ref-type="bibr" rid="R67">67</xref>].</p></sec><sec><title>PHP-Ib</title><p>Since a 3-kb deletion removing exons 4-6 of the <italic>STX16</italic> locus has been identified in numerous familial PHP-Ib cases, and since this locus, with its exon-intron structure and its proximity to the <italic>GNAS</italic> locus, is similar in mice and humans, an attempt at generating a PHP-Ib mouse model has been made through targeted deletion of <italic>Stx16</italic> exons 4-6 [<xref ref-type="bibr" rid="R167">167</xref>]. Both heterozygous and homozygous mice with this deletion lack gross abnormalities, are fertile, and appear to have a normal life span. More important, regardless of the parental origin of the deletion, the mutant mice fail to phenocopy the epigenetic abnormalities found in patients with familial PHP-Ib. In fact, neither any other <italic>Gnas</italic> methylation defects nor any biochemical features that would suggest PTH resistance could be observed in these animals. Thus, the nearly exact change in the mouse <italic>Stx16</italic> gene is not sufficient to disrupt <italic>Gnas</italic> imprinting and to result in PTH resistance, ruling out a disrupted <italic>STX16</italic> mRNA and/or protein as the molecular cause of familial PHP-Ib. This conclusion, which is consistent with the evidence that the <italic>STX16</italic> locus is not imprinted, supports the hypothesis that the deletions in this gene disrupt a cis-acting long-range regulatory element required for the proper imprinting of <italic>GNAS</italic> exon A/B. It appears that this putative control element is not located within <italic>Stx16</italic> exons 4-6 in mice.</p></sec></sec><sec sec-type="summary|conclusion"><title>SUMMARY AND CONCLUSION </title><p><italic>GNAS</italic> is a complex locus located on the telomeric end of chromosome 20q. At least five distinct promoters reside in this locus, leading to biallelically, paternally, and/or maternally expressed transcripts from both the sense and antisense strands. Expression from this locus is tightly regulated by epigenetic mechanisms and cis-acting regulatory elements, including non-coding RNA molecules. <italic>GNAS</italic> encodes Gs&#x003b1;, one of the subunits of the heterotrimeric stimulatory G protein, which is essential for the actions of numerous agonists. Several human disorders are caused by heterozygous mutations that affect Gs&#x003b1; expression and/or activity, and consistent with the tissue-specific paternal silencing of Gs&#x003b1; expression, these disorders are inherited in a parent-of-origin specific manner. In contrast to Gs&#x003b1;, the roles of most of the other <italic>GNAS</italic> products remain unknown at the cellular and molecular level, even though the biological significance of these products are clear from gene knockout studies. Depending on their parental origin, mutations that affect the Gs&#x003b1; transcript also disrupt some of the additional <italic>GNAS</italic> transcripts, such as XL&#x003b1;s. It is likely that the disruption of these additional gene products or alterations in the balance between the expression of Gs&#x003b1; and these proteins contributes to disease pathogenesis. It will therefore be important to investigate the factors regulating the expression of each <italic>GNAS</italic> product and to determine their cellular actions. Consequently, we will know more about the biological role of this gene locus and improve our understanding of the molecular mechanisms underlying the <italic>GNAS</italic>-related disorders. In addition, we will likely gain further insights into the functional significance of complex genes in the genome.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Linton</surname><given-names>LM</given-names></name><name><surname>Birren</surname><given-names>B</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Zody</surname><given-names>MC</given-names></name><name><surname>Baldwin</surname><given-names>J</given-names></name><name><surname>Devon</surname><given-names>K</given-names></name><name><surname>Dewar</surname><given-names>K</given-names></name><name><surname>Doyle</surname><given-names>M</given-names></name><name><surname>FitzHugh</surname><given-names>W</given-names></name><name><surname>Funke</surname><given-names>R</given-names></name><name><surname>Gage</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>K</given-names></name><name><surname>Heaford</surname><given-names>A</given-names></name><name><surname>Howland</surname><given-names>J</given-names></name><name><surname>Kann</surname><given-names>L</given-names></name><name><surname>Lehoczky</surname><given-names>J</given-names></name><name><surname>LeVine</surname><given-names>R</given-names></name><name><surname>McEwan</surname><given-names>P</given-names></name><name><surname>McKernan</surname><given-names>K</given-names></name><name><surname>Meldrim</surname><given-names>J</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Miranda</surname><given-names>C</given-names></name><name><surname>Morris</surname><given-names>W</given-names></name><name><surname>Naylor</surname><given-names>J</given-names></name><name><surname>Raymond</surname><given-names>C</given-names></name><name><surname>Rosetti</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>R</given-names></name><name><surname>Sheridan</surname><given-names>A</given-names></name><name><surname>Sougnez</surname><given-names>C</given-names></name><name><surname>Stange-Thomann</surname><given-names>N</given-names></name><name><surname>Stojanovic</surname><given-names>N</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Wyman</surname><given-names>D</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Sulston</surname><given-names>J</given-names></name><name><surname>Ainscough</surname><given-names>R</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Bentley</surname><given-names>D</given-names></name><name><surname>Burton</surname><given-names>J</given-names></name><name><surname>Clee</surname><given-names>C</given-names></name><name><surname>Carter</surname><given-names>N</given-names></name><name><surname>Coulson</surname><given-names>A</given-names></name><name><surname>Deadman</surname><given-names>R</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Dunham</surname><given-names>A</given-names></name><name><surname>Dunham</surname><given-names>I</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>French</surname><given-names>L</given-names></name><name><surname>Grafham</surname><given-names>D</given-names></name><name><surname>Gregory</surname><given-names>S</given-names></name><name><surname>Hubbard</surname><given-names>T</given-names></name><name><surname>Humphray</surname><given-names>S</given-names></name><name><surname>Hunt</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Lloyd</surname><given-names>C</given-names></name><name><surname>McMurray</surname><given-names>A</given-names></name><name><surname>Matthews</surname><given-names>L</given-names></name><name><surname>Mercer</surname><given-names>S</given-names></name><name><surname>Milne</surname><given-names>S</given-names></name><name><surname>Mullikin</surname><given-names>JC</given-names></name><name><surname>Mungall</surname><given-names>A</given-names></name><name><surname>Plumb</surname><given-names>R</given-names></name><name><surname>Ross</surname><given-names>M</given-names></name><name><surname>Shownkeen</surname><given-names>R</given-names></name><name><surname>Sims</surname><given-names>S</given-names></name><name><surname>Waterston</surname><given-names>RH</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Hillier</surname><given-names>LW</given-names></name><name><surname>McPherson</surname><given-names>JD</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Fulton</surname><given-names>LA</given-names></name><name><surname>Chinwalla</surname><given-names>AT</given-names></name><name><surname>Pepin</surname><given-names>KH</given-names></name><name><surname>Gish</surname><given-names>WR</given-names></name><name><surname>Chissoe</surname><given-names>SL</given-names></name><name><surname>Wendl</surname><given-names>MC</given-names></name><name><surname>Delehaunty</surname><given-names>KD</given-names></name><name><surname>Miner</surname><given-names>TL</given-names></name><name><surname>Delehaunty</surname><given-names>A</given-names></name><name><surname>Kramer</surname><given-names>JB</given-names></name><name><surname>Cook</surname><given-names>LL</given-names></name><name><surname>Fulton</surname><given-names>RS</given-names></name><name><surname>Johnson</surname><given-names>DL</given-names></name><name><surname>Minx</surname><given-names>PJ</given-names></name><name><surname>Clifton</surname><given-names>SW</given-names></name><name><surname>Hawkins</surname><given-names>T</given-names></name><name><surname>Branscomb</surname><given-names>E</given-names></name><name><surname>Predki</surname><given-names>P</given-names></name><name><surname>Richardson</surname><given-names>P</given-names></name><name><surname>Wenning</surname><given-names>S</given-names></name><name><surname>Slezak</surname><given-names>T</given-names></name><name><surname>Doggett</surname><given-names>N</given-names></name><name><surname>Cheng</surname><given-names>JF</given-names></name><name><surname>Olsen</surname><given-names>A</given-names></name><name><surname>Lucas</surname><given-names>S</given-names></name><name><surname>Elkin</surname><given-names>C</given-names></name><name><surname>Uberbacher</surname><given-names>E</given-names></name><name><surname>Frazier</surname><given-names>M</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Scherer</surname><given-names>SE</given-names></name><name><surname>Bouck</surname><given-names>JB</given-names></name><name><surname>Sodergren</surname><given-names>EJ</given-names></name><name><surname>Worley</surname><given-names>KC</given-names></name><name><surname>Rives</surname><given-names>CM</given-names></name><name><surname>Gorrell</surname><given-names>JH</given-names></name><name><surname>Metzker</surname><given-names>ML</given-names></name><name><surname>Naylor</surname><given-names>SL</given-names></name><name><surname>Kucherlapati</surname><given-names>RS</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name><name><surname>Sakaki</surname><given-names>Y</given-names></name><name><surname>Fujiyama</surname><given-names>A</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Yada</surname><given-names>T</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Kawagoe</surname><given-names>C</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Taylor</surname><given-names>T</given-names></name><name><surname>Weissenbach</surname><given-names>J</given-names></name><name><surname>Heilig</surname><given-names>R</given-names></name><name><surname>Saurin</surname><given-names>W</given-names></name><name><surname>Artiguenave</surname><given-names>F</given-names></name><name><surname>Brottier</surname><given-names>P</given-names></name><name><surname>Bruls</surname><given-names>T</given-names></name><name><surname>Pelletier</surname><given-names>E</given-names></name><name><surname>Robert</surname><given-names>C</given-names></name><name><surname>Wincker</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>DR</given-names></name><name><surname>Doucette-Stamm</surname><given-names>L</given-names></name><name><surname>Rubenfield</surname><given-names>M</given-names></name><name><surname>Weinstock</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>HM</given-names></name><name><surname>Dubois</surname><given-names>J</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name><name><surname>Platzer</surname><given-names>M</given-names></name><name><surname>Nyakatura</surname><given-names>G</given-names></name><name><surname>Taudien</surname><given-names>S</given-names></name><name><surname>Rump</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Hood</surname><given-names>L</given-names></name><name><surname>Rowen</surname><given-names>L</given-names></name><name><surname>Madan</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>RW</given-names></name><name><surname>Federspiel</surname><given-names>NA</given-names></name><name><surname>Abola</surname><given-names>AP</given-names></name><name><surname>Proctor</surname><given-names>MJ</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Schmutz</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>M</given-names></name><name><surname>Grimwood</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name><name><surname>Olson</surname><given-names>MV</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Raymond</surname><given-names>C</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Kawasaki</surname><given-names>K</given-names></name><name><surname>Minoshima</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>GA</given-names></name><name><surname>Athanasiou</surname><given-names>M</given-names></name><name><surname>Schultz</surname><given-names>R</given-names></name><name><surname>Roe</surname><given-names>BA</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Ramser</surname><given-names>J</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Reinhardt</surname><given-names>R</given-names></name><name><surname>McCombie</surname><given-names>WR</given-names></name><name><surname>de la Bastide</surname><given-names>M</given-names></name><name><surname>Dedhia</surname><given-names>N</given-names></name><name><surname>Blocker</surname><given-names>H</given-names></name><name><surname>Hornischer</surname><given-names>K</given-names></name><name><surname>Nordsiek</surname><given-names>G</given-names></name><name><surname>Agarwala</surname><given-names>R</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name><name><surname>Bailey</surname><given-names>JA</given-names></name><name><surname>Bateman</surname><given-names>A</given-names></name><name><surname>Batzoglou</surname><given-names>S</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Brown</surname><given-names>DG</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name><name><surname>Cerutti</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>HC</given-names></name><name><surname>Church</surname><given-names>D</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Copley</surname><given-names>RR</given-names></name><name><surname>Doerks</surname><given-names>T</given-names></name><name><surname>Eddy</surname><given-names>SR</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Galagan</surname><given-names>J</given-names></name><name><surname>Gilbert</surname><given-names>JG</given-names></name><name><surname>Harmon</surname><given-names>C</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Hermjakob</surname><given-names>H</given-names></name><name><surname>Hokamp</surname><given-names>K</given-names></name><name><surname>Jang</surname><given-names>W</given-names></name><name><surname>Johnson</surname><given-names>LS</given-names></name><name><surname>Jones</surname><given-names>TA</given-names></name><name><surname>Kasif</surname><given-names>S</given-names></name><name><surname>Kaspryzk</surname><given-names>A</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Kitts</surname><given-names>P</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name><name><surname>Korf</surname><given-names>I</given-names></name><name><surname>Kulp</surname><given-names>D</given-names></name><name><surname>Lancet</surname><given-names>D</given-names></name><name><surname>Lowe</surname><given-names>TM</given-names></name><name><surname>McLysaght</surname><given-names>A</given-names></name><name><surname>Mikkelsen</surname><given-names>T</given-names></name><name><surname>Moran</surname><given-names>JV</given-names></name><name><surname>Mulder</surname><given-names>N</given-names></name><name><surname>Pollara</surname><given-names>VJ</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name><name><surname>Schultz</surname><given-names>J</given-names></name><name><surname>Slater</surname><given-names>G</given-names></name><name><surname>Smit</surname><given-names>AF</given-names></name><name><surname>Stupka</surname><given-names>E</given-names></name><name><surname>Szustakowski</surname><given-names>J</given-names></name><name><surname>Thierry-Mieg</surname><given-names>D</given-names></name><name><surname>Thierry-Mieg</surname><given-names>J</given-names></name><name><surname>Wagner</surname><given-names>L</given-names></name><name><surname>Wallis</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Wolf</surname><given-names>YI</given-names></name><name><surname>Wolfe</surname><given-names>KH</given-names></name><name><surname>Yang</surname><given-names>SP</given-names></name><name><surname>Yeh</surname><given-names>RF</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Guyer</surname><given-names>MS</given-names></name><name><surname>Peterson</surname><given-names>J</given-names></name><name><surname>Felsenfeld</surname><given-names>A</given-names></name><name><surname>Wetterstrand</surname><given-names>KA</given-names></name><name><surname>Patrinos</surname><given-names>A</given-names></name><name><surname>Morgan</surname><given-names>MJ</given-names></name><name><surname>de Jong</surname><given-names>P</given-names></name><name><surname>Catanese</surname><given-names>JJ</given-names></name><name><surname>Osoegawa</surname><given-names>K</given-names></name><name><surname>Shizuya</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name></person-group><article-title>Initial sequencing and analysis of the human genome</article-title><source>Nature</source><year>2001</year><volume>409</volume><issue>6822</issue><fpage>860</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">11237011</pub-id></citation></ref><ref id="R2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venter</surname><given-names>JC</given-names></name><name><surname>Adams</surname><given-names>MD</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Li</surname><given-names>PW</given-names></name><name><surname>Mural</surname><given-names>RJ</given-names></name><name><surname>Sutton</surname><given-names>GG</given-names></name><name><surname>Smith</surname><given-names>HO</given-names></name><name><surname>Yandell</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>CA</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name><name><surname>Gocayne</surname><given-names>JD</given-names></name><name><surname>Amanatides</surname><given-names>P</given-names></name><name><surname>Ballew</surname><given-names>RM</given-names></name><name><surname>Huson</surname><given-names>DH</given-names></name><name><surname>Wortman</surname><given-names>JR</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Kodira</surname><given-names>CD</given-names></name><name><surname>Zheng</surname><given-names>XH</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Skupski</surname><given-names>M</given-names></name><name><surname>Subramanian</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Gabor Miklos</surname><given-names>GL</given-names></name><name><surname>Nelson</surname><given-names>C</given-names></name><name><surname>Broder</surname><given-names>S</given-names></name><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Nadeau</surname><given-names>J</given-names></name><name><surname>McKusick</surname><given-names>VA</given-names></name><name><surname>Zinder</surname><given-names>N</given-names></name><name><surname>Levine</surname><given-names>AJ</given-names></name><name><surname>Roberts</surname><given-names>RJ</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Slayman</surname><given-names>C</given-names></name><name><surname>Hunkapiller</surname><given-names>M</given-names></name><name><surname>Bolanos</surname><given-names>R</given-names></name><name><surname>Delcher</surname><given-names>A</given-names></name><name><surname>Dew</surname><given-names>I</given-names></name><name><surname>Fasulo</surname><given-names>D</given-names></name><name><surname>Flanigan</surname><given-names>M</given-names></name><name><surname>Florea</surname><given-names>L</given-names></name><name><surname>Halpern</surname><given-names>A</given-names></name><name><surname>Hannenhalli</surname><given-names>S</given-names></name><name><surname>Kravitz</surname><given-names>S</given-names></name><name><surname>Levy</surname><given-names>S</given-names></name><name><surname>Mobarry</surname><given-names>C</given-names></name><name><surname>Reinert</surname><given-names>K</given-names></name><name><surname>Remington</surname><given-names>K</given-names></name><name><surname>Abu-Threideh</surname><given-names>J</given-names></name><name><surname>Beasley</surname><given-names>E</given-names></name><name><surname>Biddick</surname><given-names>K</given-names></name><name><surname>Bonazzi</surname><given-names>V</given-names></name><name><surname>Brandon</surname><given-names>R</given-names></name><name><surname>Cargill</surname><given-names>M</given-names></name><name><surname>Chandramouliswaran</surname><given-names>I</given-names></name><name><surname>Charlab</surname><given-names>R</given-names></name><name><surname>Chaturvedi</surname><given-names>K</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Di Francesco</surname><given-names>V</given-names></name><name><surname>Dunn</surname><given-names>P</given-names></name><name><surname>Eilbeck</surname><given-names>K</given-names></name><name><surname>Evangelista</surname><given-names>C</given-names></name><name><surname>Gabrielian</surname><given-names>AE</given-names></name><name><surname>Gan</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Guan</surname><given-names>P</given-names></name><name><surname>Heiman</surname><given-names>TJ</given-names></name><name><surname>Higgins</surname><given-names>ME</given-names></name><name><surname>Ji</surname><given-names>RR</given-names></name><name><surname>Ke</surname><given-names>Z</given-names></name><name><surname>Ketchum</surname><given-names>KA</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Merkulov</surname><given-names>GV</given-names></name><name><surname>Milshina</surname><given-names>N</given-names></name><name><surname>Moore</surname><given-names>HM</given-names></name><name><surname>Naik</surname><given-names>AK</given-names></name><name><surname>Narayan</surname><given-names>VA</given-names></name><name><surname>Neelam</surname><given-names>B</given-names></name><name><surname>Nusskern</surname><given-names>D</given-names></name><name><surname>Rusch</surname><given-names>DB</given-names></name><name><surname>Salzberg</surname><given-names>S</given-names></name><name><surname>Shao</surname><given-names>W</given-names></name><name><surname>Shue</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Wides</surname><given-names>R</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Zhan</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>F</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Gilbert</surname><given-names>D</given-names></name><name><surname>Baumhueter</surname><given-names>S</given-names></name><name><surname>Spier</surname><given-names>G</given-names></name><name><surname>Carter</surname><given-names>C</given-names></name><name><surname>Cravchik</surname><given-names>A</given-names></name><name><surname>Woodage</surname><given-names>T</given-names></name><name><surname>Ali</surname><given-names>F</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Awe</surname><given-names>A</given-names></name><name><surname>Baldwin</surname><given-names>D</given-names></name><name><surname>Baden</surname><given-names>H</given-names></name><name><surname>Barnstead</surname><given-names>M</given-names></name><name><surname>Barrow</surname><given-names>I</given-names></name><name><surname>Beeson</surname><given-names>K</given-names></name><name><surname>Busam</surname><given-names>D</given-names></name><name><surname>Carver</surname><given-names>A</given-names></name><name><surname>Center</surname><given-names>A</given-names></name><name><surname>Cheng</surname><given-names>ML</given-names></name><name><surname>Curry</surname><given-names>L</given-names></name><name><surname>Danaher</surname><given-names>S</given-names></name><name><surname>Davenport</surname><given-names>L</given-names></name><name><surname>Desilets</surname><given-names>R</given-names></name><name><surname>Dietz</surname><given-names>S</given-names></name><name><surname>Dodson</surname><given-names>K</given-names></name><name><surname>Doup</surname><given-names>L</given-names></name><name><surname>Ferriera</surname><given-names>S</given-names></name><name><surname>Garg</surname><given-names>N</given-names></name><name><surname>Gluecksmann</surname><given-names>A</given-names></name><name><surname>Hart</surname><given-names>B</given-names></name><name><surname>Haynes</surname><given-names>J</given-names></name><name><surname>Haynes</surname><given-names>C</given-names></name><name><surname>Heiner</surname><given-names>C</given-names></name><name><surname>Hladun</surname><given-names>S</given-names></name><name><surname>Hostin</surname><given-names>D</given-names></name><name><surname>Houck</surname><given-names>J</given-names></name><name><surname>Howland</surname><given-names>T</given-names></name><name><surname>Ibegwam</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Kalush</surname><given-names>F</given-names></name><name><surname>Kline</surname><given-names>L</given-names></name><name><surname>Koduru</surname><given-names>S</given-names></name><name><surname>Love</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>F</given-names></name><name><surname>May</surname><given-names>D</given-names></name><name><surname>McCawley</surname><given-names>S</given-names></name><name><surname>McIntosh</surname><given-names>T</given-names></name><name><surname>McMullen</surname><given-names>I</given-names></name><name><surname>Moy</surname><given-names>M</given-names></name><name><surname>Moy</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>B</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name><name><surname>Pfannkoch</surname><given-names>C</given-names></name><name><surname>Pratts</surname><given-names>E</given-names></name><name><surname>Puri</surname><given-names>V</given-names></name><name><surname>Qureshi</surname><given-names>H</given-names></name><name><surname>Reardon</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>R</given-names></name><name><surname>Rogers</surname><given-names>YH</given-names></name><name><surname>Romblad</surname><given-names>D</given-names></name><name><surname>Ruhfel</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>R</given-names></name><name><surname>Sitter</surname><given-names>C</given-names></name><name><surname>Smallwood</surname><given-names>M</given-names></name><name><surname>Stewart</surname><given-names>E</given-names></name><name><surname>Strong</surname><given-names>R</given-names></name><name><surname>Suh</surname><given-names>E</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Tint</surname><given-names>NN</given-names></name><name><surname>Tse</surname><given-names>S</given-names></name><name><surname>Vech</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wetter</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Windsor</surname><given-names>S</given-names></name><name><surname>Winn-Deen</surname><given-names>E</given-names></name><name><surname>Wolfe</surname><given-names>K</given-names></name><name><surname>Zaveri</surname><given-names>J</given-names></name><name><surname>Zaveri</surname><given-names>K</given-names></name><name><surname>Abril</surname><given-names>JF</given-names></name><name><surname>Guigo</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>MJ</given-names></name><name><surname>Sjolander</surname><given-names>KV</given-names></name><name><surname>Karlak</surname><given-names>B</given-names></name><name><surname>Kejariwal</surname><given-names>A</given-names></name><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Lazareva</surname><given-names>B</given-names></name><name><surname>Hatton</surname><given-names>T</given-names></name><name><surname>Narechania</surname><given-names>A</given-names></name><name><surname>Diemer</surname><given-names>K</given-names></name><name><surname>Muruganujan</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Bafna</surname><given-names>V</given-names></name><name><surname>Istrail</surname><given-names>S</given-names></name><name><surname>Lippert</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>R</given-names></name><name><surname>Walenz</surname><given-names>B</given-names></name><name><surname>Yooseph</surname><given-names>S</given-names></name><name><surname>Allen</surname><given-names>D</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Baxendale</surname><given-names>J</given-names></name><name><surname>Blick</surname><given-names>L</given-names></name><name><surname>Caminha</surname><given-names>M</given-names></name><name><surname>Carnes-Stine</surname><given-names>J</given-names></name><name><surname>Caulk</surname><given-names>P</given-names></name><name><surname>Chiang</surname><given-names>YH</given-names></name><name><surname>Coyne</surname><given-names>M</given-names></name><name><surname>Dahlke</surname><given-names>C</given-names></name><name><surname>Mays</surname><given-names>A</given-names></name><name><surname>Dombroski</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>M</given-names></name><name><surname>Ely</surname><given-names>D</given-names></name><name><surname>Esparham</surname><given-names>S</given-names></name><name><surname>Fosler</surname><given-names>C</given-names></name><name><surname>Gire</surname><given-names>H</given-names></name><name><surname>Glanowski</surname><given-names>S</given-names></name><name><surname>Glasser</surname><given-names>K</given-names></name><name><surname>Glodek</surname><given-names>A</given-names></name><name><surname>Gorokhov</surname><given-names>M</given-names></name><name><surname>Graham</surname><given-names>K</given-names></name><name><surname>Gropman</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>M</given-names></name><name><surname>Heil</surname><given-names>J</given-names></name><name><surname>Henderson</surname><given-names>S</given-names></name><name><surname>Hoover</surname><given-names>J</given-names></name><name><surname>Jennings</surname><given-names>D</given-names></name><name><surname>Jordan</surname><given-names>C</given-names></name><name><surname>Jordan</surname><given-names>J</given-names></name><name><surname>Kasha</surname><given-names>J</given-names></name><name><surname>Kagan</surname><given-names>L</given-names></name><name><surname>Kraft</surname><given-names>C</given-names></name><name><surname>Levitsky</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Lopez</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Majoros</surname><given-names>W</given-names></name><name><surname>McDaniel</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>S</given-names></name><name><surname>Newman</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>N</given-names></name><name><surname>Nodell</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Peck</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>M</given-names></name><name><surname>Rowe</surname><given-names>W</given-names></name><name><surname>Sanders</surname><given-names>R</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Simpson</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Sprague</surname><given-names>A</given-names></name><name><surname>Stockwell</surname><given-names>T</given-names></name><name><surname>Turner</surname><given-names>R</given-names></name><name><surname>Venter</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>A</given-names></name><name><surname>Zandieh</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><article-title>The sequence of the human genome</article-title><source>Science</source><year>2001</year><volume>291</volume><issue>5507</issue><fpage>1304</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">11181995</pub-id></citation></ref><ref id="R3"><label>3</label><citation citation-type="journal"><article-title>Finishing the euchromatic sequence of the human genome</article-title><source>Nature</source><year>2004</year><volume>431</volume><issue>7011</issue><fpage>931</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">15496913</pub-id></citation></ref><ref id="R4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmutz</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>J</given-names></name><name><surname>Grimwood</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Caoile</surname><given-names>C</given-names></name><name><surname>Bajorek</surname><given-names>E</given-names></name><name><surname>Black</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>YM</given-names></name><name><surname>Denys</surname><given-names>M</given-names></name><name><surname>Escobar</surname><given-names>J</given-names></name><name><surname>Flowers</surname><given-names>D</given-names></name><name><surname>Fotopulos</surname><given-names>D</given-names></name><name><surname>Garcia</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>M</given-names></name><name><surname>Gonzales</surname><given-names>E</given-names></name><name><surname>Haydu</surname><given-names>L</given-names></name><name><surname>Lopez</surname><given-names>F</given-names></name><name><surname>Ramirez</surname><given-names>L</given-names></name><name><surname>Retterer</surname><given-names>J</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Rogers</surname><given-names>S</given-names></name><name><surname>Salazar</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name></person-group><article-title>Quality assessment of the human genome sequence</article-title><source>Nature</source><year>2004</year><volume>429</volume><issue>6990</issue><fpage>365</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15164052</pub-id></citation></ref><ref id="R5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>LD</given-names></name></person-group><article-title>Human genome: end of the beginning</article-title><source>Nature</source><year>2004</year><volume>431</volume><issue>7011</issue><fpage>915</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15496902</pub-id></citation></ref><ref id="R6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aparicio</surname><given-names>SA</given-names></name></person-group><article-title>How to count human genes</article-title><source>Nat. Genet</source><year>2000</year><volume>25</volume><issue>2</issue><fpage>129</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">10835617</pub-id></citation></ref><ref id="R7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ewing</surname><given-names>B</given-names></name><name><surname>Green</surname><given-names>P</given-names></name></person-group><article-title>Analysis of expressed sequence tags indicates 35,000 human genes</article-title><source>Nat. Genet</source><year>2000</year><volume>25</volume><issue>2</issue><fpage>232</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10835644</pub-id></citation></ref><ref id="R8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>F</given-names></name><name><surname>Holt</surname><given-names>I</given-names></name><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Karamycheva</surname><given-names>S</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><name><surname>Quackenbush</surname><given-names>J</given-names></name></person-group><article-title>Gene index analysis of the human genome estimates approximately 120,000 genes</article-title><source>Nat. Genet</source><year>2000</year><volume>25</volume><issue>2</issue><fpage>239</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">10835646</pub-id></citation></ref><ref id="R9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roest Crollius</surname><given-names>H</given-names></name><name><surname>Jaillon</surname><given-names>O</given-names></name><name><surname>Bernot</surname><given-names>A</given-names></name><name><surname>Dasilva</surname><given-names>C</given-names></name><name><surname>Bouneau</surname><given-names>L</given-names></name><name><surname>Fischer</surname><given-names>C</given-names></name><name><surname>Fizames</surname><given-names>C</given-names></name><name><surname>Wincker</surname><given-names>P</given-names></name><name><surname>Brottier</surname><given-names>P</given-names></name><name><surname>Quetier</surname><given-names>F</given-names></name><name><surname>Saurin</surname><given-names>W</given-names></name><name><surname>Weissenbach</surname><given-names>J</given-names></name></person-group><article-title>Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence</article-title><source>Nat. Genet</source><year>2000</year><volume>25</volume><issue>2</issue><fpage>235</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10835645</pub-id></citation></ref><ref id="R10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gejman</surname><given-names>PV</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Martinez</surname><given-names>M</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Hsieh</surname><given-names>WT</given-names></name><name><surname>Hoehe</surname><given-names>MR</given-names></name><name><surname>Gershon</surname><given-names>ES</given-names></name></person-group><article-title>Genetic mapping of the Gs&#x003b1; subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis</article-title><source>Genomics</source><year>1991</year><volume>9</volume><fpage>782</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">1674732</pub-id></citation></ref><ref id="R11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>VV</given-names></name><name><surname>Schnittger</surname><given-names>S</given-names></name><name><surname>Hansmann</surname><given-names>I</given-names></name></person-group><article-title>G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy is assigned to human chromosome 20q12-q13.2</article-title><source>Genomics</source><year>1991</year><volume>10</volume><issue>1</issue><fpage>257</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">1904395</pub-id></citation></ref><ref id="R12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Modi</surname><given-names>WS</given-names></name><name><surname>O'Brien</surname><given-names>SJ</given-names></name></person-group><article-title>Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2----q13.3 in human by in situ hybridization</article-title><source>Genomics</source><year>1991</year><volume>11</volume><issue>2</issue><fpage>478</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1769666</pub-id></citation></ref><ref id="R13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blatt</surname><given-names>C</given-names></name><name><surname>Eversole-Cire</surname><given-names>P</given-names></name><name><surname>Cohn</surname><given-names>VH</given-names></name><name><surname>Zollman</surname><given-names>S</given-names></name><name><surname>Fournier</surname><given-names>RE</given-names></name><name><surname>Mohandas</surname><given-names>LT</given-names></name><name><surname>Nesbitt</surname><given-names>M</given-names></name><name><surname>Lugo</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>DT</given-names></name><name><surname>Reed</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1988</year><volume>85</volume><issue>20</issue><fpage>7642</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2902634</pub-id></citation></ref><ref id="R14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Beechey</surname><given-names>CV</given-names></name><name><surname>Ball</surname><given-names>ST</given-names></name><name><surname>Evans</surname><given-names>EP</given-names></name></person-group><article-title>Mapping studies of the distal imprinting region of mouse chromosome 2</article-title><source>Genet. Res</source><year>1994</year><volume>63</volume><issue>3</issue><fpage>169</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">8082833</pub-id></citation></ref><ref id="R15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>YC</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Lowry</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name></person-group><article-title>Src tyrosine kinase is a novel direct effector of G proteins</article-title><source>Cell</source><year>2000</year><volume>102</volume><issue>5</issue><fpage>635</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11007482</pub-id></citation></ref><ref id="R16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yatani</surname><given-names>A</given-names></name><name><surname>Imoto</surname><given-names>Y</given-names></name><name><surname>Codina</surname><given-names>J</given-names></name><name><surname>Hamilton</surname><given-names>SL</given-names></name><name><surname>Brown</surname><given-names>AM</given-names></name><name><surname>Birnbaumer</surname><given-names>L</given-names></name></person-group><article-title>The stimulatory G protein of adenylyl cyclase, Gs, also stimulates dihydropyridine-sensitive Ca2+ channels. Evidence for direct regulation independent of phosphorylation by cAMP-dependent protein kinase or stimulation by a dihydropyridine agonist</article-title><source>J. Biol. Chem</source><year>1988</year><volume>263</volume><issue>20</issue><fpage>9887</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">2454923</pub-id></citation></ref><ref id="R17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattera</surname><given-names>R</given-names></name><name><surname>Graziano</surname><given-names>MP</given-names></name><name><surname>Yatani</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Graf</surname><given-names>R</given-names></name><name><surname>Codina</surname><given-names>J</given-names></name><name><surname>Birnbaumer</surname><given-names>L</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Brown</surname><given-names>AM</given-names></name></person-group><article-title>Splice variants of the alpha subunit of the G protein Gs activate both adenylyl cyclase and calcium channels</article-title><source>Science</source><year>1989</year><volume>243</volume><issue>4892</issue><fpage>804</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2536957</pub-id></citation></ref><ref id="R18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sondek</surname><given-names>J</given-names></name><name><surname>Lambright</surname><given-names>DG</given-names></name><name><surname>Noel</surname><given-names>JP</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name></person-group><article-title>GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4</article-title><source>Nature</source><year>1994</year><volume>372</volume><issue>6503</issue><fpage>276</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7969474</pub-id></citation></ref><ref id="R19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>DE</given-names></name><name><surname>Berghuis</surname><given-names>AM</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Linder</surname><given-names>ME</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Sprang</surname><given-names>SR</given-names></name></person-group><article-title>Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis</article-title><source>Science</source><year>1994</year><volume>265</volume><issue>5177</issue><fpage>1405</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">8073283</pub-id></citation></ref><ref id="R20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Landis</surname><given-names>CA</given-names></name><name><surname>Masters</surname><given-names>SB</given-names></name><name><surname>Spada</surname><given-names>A</given-names></name><name><surname>Pace</surname><given-names>AM</given-names></name><name><surname>Bourne</surname><given-names>HR</given-names></name><name><surname>Vallar</surname><given-names>L</given-names></name></person-group><article-title>GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours</article-title><source>Nature</source><year>1989</year><volume>340</volume><issue>6236</issue><fpage>692</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2549426</pub-id></citation></ref><ref id="R21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graziano</surname><given-names>MP</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name></person-group><article-title>Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha</article-title><source>J. Biol. Chem</source><year>1989</year><volume>264</volume><issue>26</issue><fpage>15475</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">2549065</pub-id></citation></ref><ref id="R22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabrera-Vera</surname><given-names>TM</given-names></name><name><surname>Vanhauwe</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>TO</given-names></name><name><surname>Medkova</surname><given-names>M</given-names></name><name><surname>Preininger</surname><given-names>A</given-names></name><name><surname>Mazzoni</surname><given-names>MR</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name></person-group><article-title>Insights into G protein structure, function, and regulation</article-title><source>Endocr. Rev</source><year>2003</year><volume>24</volume><issue>6</issue><fpage>765</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">14671004</pub-id></citation></ref><ref id="R23"><label>23</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>Introduction to G-protein-coupled signal transduction and human disease</article-title><source>G proteins, receptors, and disease</source><year>1998</year><publisher-loc>Totowa, New Jersey </publisher-loc><publisher-name>Humana Press</publisher-name><fpage>1</fpage><lpage>21</lpage></citation></ref><ref id="R24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozasa</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Tsukamoto</surname><given-names>T</given-names></name><name><surname>Kaziro</surname><given-names>Y</given-names></name></person-group><article-title>Isolation and characterization of the human Gs&#x003b1; gene</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1988</year><volume>85</volume><fpage>2081</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">3127824</pub-id></citation></ref><ref id="R25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>P</given-names></name><name><surname>Carter</surname><given-names>A</given-names></name><name><surname>Simons</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>V</given-names></name><name><surname>Puckett</surname><given-names>C</given-names></name><name><surname>Kamholz</surname><given-names>J</given-names></name><name><surname>Spiegel</surname><given-names>A</given-names></name><name><surname>Nirenberg</surname><given-names>M</given-names></name></person-group><article-title>Human cDNA clones for four species of G alpha s signal transduction protein</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1986</year><volume>83</volume><issue>23</issue><fpage>8893</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3024154</pub-id></citation></ref><ref id="R26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robishaw</surname><given-names>JD</given-names></name><name><surname>Smigel</surname><given-names>MD</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name></person-group><article-title>Molecular basis for two forms of the G protein that stimulates adenylate cyclase</article-title><source>J. Biol. Chem</source><year>1986</year><volume>261</volume><issue>21</issue><fpage>9587</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">3015900</pub-id></citation></ref><ref id="R27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sternweis</surname><given-names>PC</given-names></name><name><surname>Northup</surname><given-names>JK</given-names></name><name><surname>Smigel</surname><given-names>MD</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name></person-group><article-title>The regulatory component of adenylate cyclase. Purification and properties</article-title><source>J. Biol. Chem</source><year>1981</year><volume>256</volume><issue>22</issue><fpage>11517</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">6271754</pub-id></citation></ref><ref id="R28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walseth</surname><given-names>TF</given-names></name><name><surname>Zhang</surname><given-names>HJ</given-names></name><name><surname>Olson</surname><given-names>LK</given-names></name><name><surname>Schroeder</surname><given-names>WA</given-names></name><name><surname>Robertson</surname><given-names>RP</given-names></name></person-group><article-title>Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit</article-title><source>J. Biol. Chem</source><year>1989</year><volume>264</volume><issue>35</issue><fpage>21106</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">2556393</pub-id></citation></ref><ref id="R29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graziano</surname><given-names>MP</given-names></name><name><surname>Freissmuth</surname><given-names>M</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name></person-group><article-title>Expression of Gs alpha in Escherichia coli. Purification and properties of two forms of the protein</article-title><source>J. Biol. Chem</source><year>1989</year><volume>264</volume><issue>1</issue><fpage>409</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">2491850</pub-id></citation></ref><ref id="R30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seifert</surname><given-names>R</given-names></name><name><surname>Wenzel-Seifert</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>TW</given-names></name><name><surname>Gether</surname><given-names>U</given-names></name><name><surname>Sanders-Bush</surname><given-names>E</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name></person-group><article-title>Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adreno-receptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor</article-title><source>J. Biol. Chem</source><year>1998</year><volume>273</volume><issue>9</issue><fpage>5109</fpage><lpage>16</lpage></citation></ref><ref id="R31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kvapil</surname><given-names>P</given-names></name><name><surname>Novotny</surname><given-names>J</given-names></name><name><surname>Svoboda</surname><given-names>P</given-names></name><name><surname>Ransnas</surname><given-names>LA</given-names></name></person-group><article-title>The short and long forms of the alpha subunit of the stimulatory guanine-nucleotide-binding protein are unequally redistributed during (-)-isoproterenol-mediated desensitization of intact S49 lymphoma cells</article-title><source>Eur. J. Biochem</source><year>1994</year><volume>226</volume><issue>1</issue><fpage>193</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7957248</pub-id></citation></ref><ref id="R32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>el Jamali</surname><given-names>A</given-names></name><name><surname>Rachdaoui</surname><given-names>N</given-names></name><name><surname>Jacquemin</surname><given-names>C</given-names></name><name><surname>Correze</surname><given-names>C</given-names></name></person-group><article-title>Long-term effect of forskolin on the activation of adenylyl cyclase in astrocytes</article-title><source>J. Neurochem</source><year>1996</year><volume>67</volume><issue>6</issue><fpage>2532</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8931487</pub-id></citation></ref><ref id="R33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourgeois</surname><given-names>C</given-names></name><name><surname>Duc-Goiran</surname><given-names>P</given-names></name><name><surname>Robert</surname><given-names>B</given-names></name><name><surname>Mondon</surname><given-names>F</given-names></name><name><surname>Ferre</surname><given-names>F</given-names></name></person-group><article-title>G protein expression in human fetoplacental vascularization. Functional evidence for Gs alpha and Gi alpha subunits</article-title><source>J. Mol. Cell Cardiol</source><year>1996</year><volume>28</volume><issue>5</issue><fpage>1009</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8762039</pub-id></citation></ref><ref id="R34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thiele</surname><given-names>S</given-names></name><name><surname>Werner</surname><given-names>R</given-names></name><name><surname>Ahrens</surname><given-names>W</given-names></name><name><surname>Hoppe</surname><given-names>U</given-names></name><name><surname>Marschke</surname><given-names>C</given-names></name><name><surname>Staedt</surname><given-names>P</given-names></name><name><surname>Hiort</surname><given-names>O</given-names></name></person-group><article-title>A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency</article-title><source>J. Clin. Endocrinol. Metab</source><year>2007</year><volume>92</volume><issue>5</issue><fpage>1764</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17299070</pub-id></citation></ref><ref id="R35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>JA</given-names></name><name><surname>Mutchler</surname><given-names>KJ</given-names></name><name><surname>Sullivan</surname><given-names>BE</given-names></name><name><surname>Lanigan</surname><given-names>TM</given-names></name><name><surname>Clark</surname><given-names>MS</given-names></name><name><surname>Russo</surname><given-names>AF</given-names></name></person-group><article-title>Neural expression of a novel alternatively spliced and polyadenylated Gs alpha transcript</article-title><source>J. Biol. Chem</source><year>1993</year><volume>268</volume><issue>13</issue><fpage>9879</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">8486667</pub-id></citation></ref><ref id="R36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>B</given-names></name><name><surname>Kamiya</surname><given-names>M</given-names></name><name><surname>Strain</surname><given-names>L</given-names></name><name><surname>Moran</surname><given-names>V</given-names></name><name><surname>Campbell</surname><given-names>R</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Bronthon</surname><given-names>DT</given-names></name></person-group><article-title>The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1998</year><volume>95</volume><fpage>10038</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">9707596</pub-id></citation></ref><ref id="R37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>BE</given-names></name><name><surname>Moran</surname><given-names>V</given-names></name><name><surname>Strain</surname><given-names>L</given-names></name><name><surname>Bonthron</surname><given-names>DT</given-names></name></person-group><article-title>Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1998</year><volume>95</volume><fpage>15475</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">9860993</pub-id></citation></ref><ref id="R38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Radeva</surname><given-names>G</given-names></name><name><surname>McCann</surname><given-names>JA</given-names></name><name><surname>Hendy</surname><given-names>GN</given-names></name><name><surname>Goodyer</surname><given-names>CG</given-names></name></person-group><article-title>G&#x003b1;s transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type Ib</article-title><source>J. Clin. Endocrinol. Metab</source><year>2001</year><volume>86</volume><issue>10</issue><fpage>4627</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11600515</pub-id></citation></ref><ref id="R39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>R</given-names></name><name><surname>Gosden</surname><given-names>CM</given-names></name><name><surname>Bonthron</surname><given-names>DT</given-names></name></person-group><article-title>Parental origin of transcription from the human GNAS1 gene</article-title><source>J. Med. Genet</source><year>1994</year><volume>31</volume><fpage>607</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">7815417</pub-id></citation></ref><ref id="R40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Eckhaus</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Corria</surname><given-names>Z</given-names></name><name><surname>Accili</surname><given-names>D</given-names></name><name><surname>Westphal</surname><given-names>H</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Variable and tissue-specific hormone resistance in heterotrimeric G<sub>s</sub> protein &#x003b1;-subunit (G<sub>s</sub>&#x003b1;) knockout mice is due to tissue-specific imprinting of the Gs&#x003b1; gene</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1998</year><volume>95</volume><fpage>8715</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9671744</pub-id></citation></ref><ref id="R41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Germain-Lee</surname><given-names>EL</given-names></name><name><surname>Schwindinger</surname><given-names>W</given-names></name><name><surname>Crane</surname><given-names>JL</given-names></name><name><surname>Zewdu</surname><given-names>R</given-names></name><name><surname>Zweifel</surname><given-names>LS</given-names></name><name><surname>Wand</surname><given-names>G</given-names></name><name><surname>Huso</surname><given-names>DL</given-names></name><name><surname>Saji</surname><given-names>M</given-names></name><name><surname>Ringel</surname><given-names>MD</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>A Mouse Model of Albright Hereditary Osteodystrophy Generated by Targeted Disruption of Exon 1 of the Gnas Gene</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><issue>11</issue><fpage>4697</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">16099856</pub-id></citation></ref><ref id="R42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Greene</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Tissue-specific imprinting of the G protein Gsalpha is associated with tissue-specific differences in histone methylation</article-title><source>Hum. Mol. Genet</source><year>2004</year><volume>13</volume><issue>8</issue><fpage>819</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">14976161</pub-id></citation></ref><ref id="R43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>B</given-names></name><name><surname>Barlier</surname><given-names>A</given-names></name><name><surname>Korbonits</surname><given-names>M</given-names></name><name><surname>Grossman</surname><given-names>A</given-names></name><name><surname>Jacquet</surname><given-names>P</given-names></name><name><surname>Enjalbert</surname><given-names>A</given-names></name><name><surname>Bonthron</surname><given-names>D</given-names></name></person-group><article-title>Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly</article-title><source>J. Clin. Invest</source><year>2001</year><volume>107</volume><fpage>R31</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11254676</pub-id></citation></ref><ref id="R44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>G</given-names></name><name><surname>Ballare</surname><given-names>E</given-names></name><name><surname>Giammona</surname><given-names>E</given-names></name><name><surname>Beck-Peccoz</surname><given-names>P</given-names></name><name><surname>Spada</surname><given-names>A</given-names></name></person-group><article-title>The Gsalpha Gene: Predominant Maternal Origin of Transcription in Human Thyroid Gland and Gonads</article-title><source>J. Clin. Endocrinol. Metab</source><year>2002</year><volume>87</volume><issue>10</issue><fpage>4736</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">12364467</pub-id></citation></ref><ref id="R45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Germain-Lee</surname><given-names>EL</given-names></name><name><surname>Ding</surname><given-names>CL</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Crane</surname><given-names>JL</given-names></name><name><surname>Saji</surname><given-names>M</given-names></name><name><surname>Ringel</surname><given-names>MD</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a</article-title><source>Biochem. Biophys. Res. Commun</source><year>2002</year><volume>296</volume><issue>1</issue><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12147228</pub-id></citation></ref><ref id="R46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>G</given-names></name><name><surname>Bondioni</surname><given-names>S</given-names></name><name><surname>Locatelli</surname><given-names>M</given-names></name><name><surname>Pedroni</surname><given-names>C</given-names></name><name><surname>Lania</surname><given-names>AG</given-names></name><name><surname>Ferrante</surname><given-names>E</given-names></name><name><surname>Filopanti</surname><given-names>M</given-names></name><name><surname>Beck-Peccoz</surname><given-names>P</given-names></name><name><surname>Spada</surname><given-names>A</given-names></name></person-group><article-title>Biallelic expression of the Gsalpha gene in human bone and adipose tissue</article-title><source>J. Clin. Endocrinol. Metab</source><year>2004</year><volume>89</volume><issue>12</issue><fpage>6316</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15579796</pub-id></citation></ref><ref id="R47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michienzi</surname><given-names>S</given-names></name><name><surname>Cherman</surname><given-names>N</given-names></name><name><surname>Holmbeck</surname><given-names>K</given-names></name><name><surname>Funari</surname><given-names>A</given-names></name><name><surname>Collins</surname><given-names>MT</given-names></name><name><surname>Bianco</surname><given-names>P</given-names></name><name><surname>Robey</surname><given-names>PG</given-names></name><name><surname>Riminucci</surname><given-names>M</given-names></name></person-group><article-title>GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs{alpha}</article-title><source>Hum. Mol. Genet</source><year>2007</year><volume>16</volume><issue>16</issue><fpage>1921</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">17566083</pub-id></citation></ref><ref id="R48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Oppermann</surname><given-names>M</given-names></name><name><surname>Faulhaber-Walter</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>YG</given-names></name><name><surname>Mizel</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Sequeira Lopez</surname><given-names>ML</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Gomez</surname><given-names>RA</given-names></name><name><surname>Briggs</surname><given-names>JP</given-names></name><name><surname>Schnermann</surname><given-names>JB</given-names></name></person-group><article-title>Regulation of renin in mice with cre recombinase-mediated deletion of G protein Gs{alpha} in juxtaglomerular cells</article-title><source>Am. J. Physiol. Renal Physiol</source><year>2006</year></citation></ref><ref id="R49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Zhao</surname><given-names>WQ</given-names></name><name><surname>Nguyen</surname><given-names>A</given-names></name><name><surname>Lorenzo</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Nackers</surname><given-names>L</given-names></name><name><surname>Pack</surname><given-names>S</given-names></name><name><surname>Jou</surname><given-names>W</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency</article-title><source>J. Clin. Invest</source><year>2005</year><volume>115</volume><issue>11</issue><fpage>3217</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">16239968</pub-id></citation></ref><ref id="R50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation</article-title><source>J. Bone Miner. Res</source><year>2005</year><volume>20</volume><issue>4</issue><fpage>663</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15765186</pub-id></citation></ref><ref id="R51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Deficiency of the G protein alpha -subunit Gsalpha in osteoblasts leads to differential effects on trabecular and cortical bone</article-title><source>J. Biol. Chem</source><year>2005</year></citation></ref><ref id="R52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Wroe</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>HJ</given-names></name><name><surname>Bodle</surname><given-names>D</given-names></name><name><surname>Beechey</surname><given-names>CV</given-names></name><name><surname>Williamson</surname><given-names>CM</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name></person-group><article-title>A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1999</year><volume>96</volume><fpage>3830</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10097123</pub-id></citation></ref><ref id="R53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ischia</surname><given-names>R</given-names></name><name><surname>Lovisetti-Scamihorn</surname><given-names>P</given-names></name><name><surname>Hogue-Angeletti</surname><given-names>R</given-names></name><name><surname>Wolkersdorfer</surname><given-names>M</given-names></name><name><surname>Winkler</surname><given-names>H</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name></person-group><article-title>Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity</article-title><source>J. Biol. Chem</source><year>1997</year><volume>272</volume><fpage>11657</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9111083</pub-id></citation></ref><ref id="R54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovisetti-Scamihorn</surname><given-names>P</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name><name><surname>Leitner</surname><given-names>B</given-names></name><name><surname>Scherzer</surname><given-names>G</given-names></name><name><surname>Winkler</surname><given-names>H</given-names></name></person-group><article-title>Relative amounts and molecular forms of NESP55 in various bovine tissues</article-title><source>Brain Res</source><year>1999</year><volume>829</volume><issue>1-2</issue><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">10350534</pub-id></citation></ref><ref id="R55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>U</given-names></name><name><surname>Ischia</surname><given-names>R</given-names></name><name><surname>Eder</surname><given-names>S</given-names></name><name><surname>Lovisetti-Scamihorn</surname><given-names>P</given-names></name><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name></person-group><article-title>Neuroendocrine secretory protein 55 (NESP55): alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein</article-title><source>Neuroendocrinology</source><year>2000</year><volume>71</volume><issue>3</issue><fpage>177</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">10729789</pub-id></citation></ref><ref id="R56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>C</given-names></name><name><surname>Marksteiner</surname><given-names>J</given-names></name><name><surname>Doblinger</surname><given-names>A</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name><name><surname>Laslop</surname><given-names>A</given-names></name></person-group><article-title>The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla</article-title><source>Neurosci. Lett</source><year>1999</year><volume>263</volume><issue>1</issue><fpage>13</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10218899</pub-id></citation></ref><ref id="R57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name><name><surname>Eder</surname><given-names>S</given-names></name><name><surname>Lovisetti-Scamihorn</surname><given-names>P</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Laslop</surname><given-names>A</given-names></name></person-group><article-title>Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathway</article-title><source>Ann. N. Y. Acad. Sci</source><year>2002</year><volume>971</volume><fpage>317</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12438142</pub-id></citation></ref><ref id="R58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Lovisetti-Scamihorn</surname><given-names>P</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name><name><surname>Winkler</surname><given-names>H</given-names></name><name><surname>Dahlstrom</surname><given-names>A</given-names></name></person-group><article-title>Distribution and intraneuronal trafficking of a novel member of the chromogranin family, NESP55, in the rat peripheral nervous system</article-title><source>Neuroscience</source><year>2002</year><volume>110</volume><issue>4</issue><fpage>731</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">11934480</pub-id></citation></ref><ref id="R59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eder</surname><given-names>S</given-names></name><name><surname>Leierer</surname><given-names>J</given-names></name><name><surname>Klimaschewski</surname><given-names>L</given-names></name><name><surname>Wilhelm</surname><given-names>A</given-names></name><name><surname>Volknandt</surname><given-names>W</given-names></name><name><surname>Laslop</surname><given-names>A</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name></person-group><article-title>Secretion and molecular forms of NESP55, a novel genomically imprinted neuroendocrine-specific protein from AtT-20 cells</article-title><source>Neurosignals</source><year>2004</year><volume>13</volume><issue>6</issue><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">15627817</pub-id></citation></ref><ref id="R60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plagge</surname><given-names>A</given-names></name><name><surname>Isles</surname><given-names>AR</given-names></name><name><surname>Gordon</surname><given-names>E</given-names></name><name><surname>Humby</surname><given-names>T</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Gritsch</surname><given-names>S</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name><name><surname>Wilkinson</surname><given-names>LS</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name></person-group><article-title>Imprinted Nesp55 influences behavioral reactivity to novel environments</article-title><source>Mol. Cell Biol</source><year>2005</year><volume>25</volume><issue>8</issue><fpage>3019</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">15798190</pub-id></citation></ref><ref id="R61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Ischia</surname><given-names>R</given-names></name><name><surname>Marksteiner</surname><given-names>J</given-names></name><name><surname>Kapeller</surname><given-names>I</given-names></name><name><surname>Fischer-Colbrie</surname><given-names>R</given-names></name></person-group><article-title>Localization of neuroendocrine secretory protein 55 messenger RNA in the rat brain</article-title><source>Neuroscience</source><year>1999</year><volume>91</volume><issue>2</issue><fpage>685</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10366025</pub-id></citation></ref><ref id="R62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linglart</surname><given-names>A</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus</article-title><source>Clin. Endocrinol. (Oxf)</source><year>2007</year></citation></ref><ref id="R63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Litman</surname><given-names>D</given-names></name><name><surname>Rosenberg</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Biesecker</surname><given-names>L</given-names></name><name><surname>Weinstein</surname><given-names>L</given-names></name></person-group><article-title>A GNAS1 imprinting defect in pseudohypoparathyroidism type IB</article-title><source>J. Clin. Invest</source><year>2000</year><volume>106</volume><fpage>1167</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">11067869</pub-id></citation></ref><ref id="R64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kehlenbach</surname><given-names>RH</given-names></name><name><surname>Matthey</surname><given-names>J</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><article-title>XL&#x003b1;s is a new type of G protein (Erratum in Nature 1995 375:253)</article-title><source>Nature</source><year>1994</year><volume>372</volume><fpage>804</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7997272</pub-id></citation></ref><ref id="R65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Vu</surname><given-names>TH</given-names></name><name><surname>Zeng</surname><given-names>ZL</given-names></name><name><surname>Nguyen</surname><given-names>BT</given-names></name><name><surname>Hayward</surname><given-names>BE</given-names></name><name><surname>Bonthron</surname><given-names>DT</given-names></name><name><surname>Hu</surname><given-names>JF</given-names></name><name><surname>Hoffman</surname><given-names>AR</given-names></name></person-group><article-title>Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus</article-title><source>Genomics</source><year>2000</year><volume>69</volume><issue>3</issue><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">11056047</pub-id></citation></ref><ref id="R66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasolli</surname><given-names>H</given-names></name><name><surname>Klemke</surname><given-names>M</given-names></name><name><surname>Kehlenbach</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Huttner</surname><given-names>W</given-names></name></person-group><article-title>Characterization of the extra-large G protein alpha-subunit XLalphas.I. Tissue distribution and subcellular localization</article-title><source>J. Biol. Chem</source><year>2000</year><volume>275</volume><fpage>33622</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10931823</pub-id></citation></ref><ref id="R67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plagge</surname><given-names>A</given-names></name><name><surname>Gordon</surname><given-names>E</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Boiani</surname><given-names>R</given-names></name><name><surname>Cinti</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name></person-group><article-title>The imprinted signaling protein XLalphas is required for postnatal adaptation to feeding</article-title><source>Nat. Genet</source><year>2004</year><volume>36</volume><issue>8</issue><fpage>818</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">15273686</pub-id></citation></ref><ref id="R68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasolli</surname><given-names>H</given-names></name><name><surname>Huttner</surname><given-names>W</given-names></name></person-group><article-title>Expression of the extra-large G protein alpha-subunit XLalphas in neuroepithelial cells and young neurons during development of the rat nervous system</article-title><source>Neurosci. Lett</source><year>2001</year><volume>301</volume><fpage>119</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">11248437</pub-id></citation></ref><ref id="R69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klemke</surname><given-names>M</given-names></name><name><surname>Pasolli</surname><given-names>H</given-names></name><name><surname>Kehlenbach</surname><given-names>R</given-names></name><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Huttner</surname><given-names>W</given-names></name></person-group><article-title>Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties</article-title><source>J. Biol. Chem</source><year>2000</year><volume>275</volume><fpage>33633</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">10931851</pub-id></citation></ref><ref id="R70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linglart</surname><given-names>A</given-names></name><name><surname>Mahon</surname><given-names>MJ</given-names></name><name><surname>Kerachian</surname><given-names>MA</given-names></name><name><surname>Berlach</surname><given-names>DM</given-names></name><name><surname>Hendy</surname><given-names>GN</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name></person-group><article-title>Coding GNAS mutations leading to hormone resistance impair <italic>in vitro</italic> agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XL&#x003b1;s</article-title><source>Endocrinology</source><year>2006</year><volume>147</volume><issue>5</issue><fpage>2253</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16484323</pub-id></citation></ref><ref id="R71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Gunes</surname><given-names>Y</given-names></name><name><surname>Perez-Villamil</surname><given-names>B</given-names></name><name><surname>Hunzelman</surname><given-names>J</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Receptor-Mediated Adenylyl Cyclase Activation Through XLalphas, the Extra-Large Variant of the Stimulatory G Protein alpha-Subunit</article-title><source>Mol. Endocrinol</source><year>2002</year><volume>16</volume><issue>8</issue><fpage>1912</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12145344</pub-id></citation></ref><ref id="R72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>J</given-names></name><name><surname>Grenet</surname><given-names>D</given-names></name><name><surname>Birnbaumer</surname><given-names>M</given-names></name><name><surname>Torres</surname><given-names>HN</given-names></name><name><surname>Birnbaumer</surname><given-names>L</given-names></name></person-group><article-title>XLalphas, the extra-long form of the alpha-subunit of the Gs G protein, is significantly longer than suspected, and so is its companion Alex</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>2004</year><volume>101</volume><issue>22</issue><fpage>8366</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15148396</pub-id></citation></ref><ref id="R73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klemke</surname><given-names>M</given-names></name><name><surname>Kehlenbach</surname><given-names>RH</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><article-title>Two overlapping reading frames in a single exon encode interacting proteins--a novel way of gene usage</article-title><source>EMBO J</source><year>2001</year><volume>20</volume><issue>14</issue><fpage>3849</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11447126</pub-id></citation></ref><ref id="R74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freson</surname><given-names>K</given-names></name><name><surname>Jaeken</surname><given-names>J</given-names></name><name><surname>Van Helvoirt</surname><given-names>M</given-names></name><name><surname>de Zegher</surname><given-names>F</given-names></name><name><surname>Wittevrongel</surname><given-names>C</given-names></name><name><surname>Thys</surname><given-names>C</given-names></name><name><surname>Hoylaerts</surname><given-names>MF</given-names></name><name><surname>Vermylen</surname><given-names>J</given-names></name><name><surname>Van Geet</surname><given-names>C</given-names></name></person-group><article-title>Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation</article-title><source>Hum. Mol. Genet</source><year>2003</year><volume>12</volume><issue>10</issue><fpage>1121</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">12719376</pub-id></citation></ref><ref id="R75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freson</surname><given-names>K</given-names></name><name><surname>Hoylaerts</surname><given-names>MF</given-names></name><name><surname>Jaeken</surname><given-names>J</given-names></name><name><surname>Eyssen</surname><given-names>M</given-names></name><name><surname>Arnout</surname><given-names>J</given-names></name><name><surname>Vermylen</surname><given-names>J</given-names></name><name><surname>Van Geet</surname><given-names>C</given-names></name></person-group><article-title>Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding</article-title><source>Thromb. Haemost</source><year>2001</year><volume>86</volume><issue>3</issue><fpage>733</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11583302</pub-id></citation></ref><ref id="R76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Plagge</surname><given-names>A</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Pack</surname><given-names>S</given-names></name><name><surname>Jou</surname><given-names>W</given-names></name><name><surname>Lai</surname><given-names>EW</given-names></name><name><surname>Frontera</surname><given-names>M</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice</article-title><source>J. Biol. Chem</source><year>2006</year><volume>281</volume><issue>28</issue><fpage>18989</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">16672216</pub-id></citation></ref><ref id="R77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Castle</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Increased insulin sensitivity in Gsalpha knockout mice</article-title><source>J. Biol. Chem</source><year>2001</year><volume>276</volume><issue>23</issue><fpage>19994</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11274197</pub-id></citation></ref><ref id="R78"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Pacak</surname><given-names>K</given-names></name><name><surname>Parlow</surname><given-names>A</given-names></name><name><surname>Quon</surname><given-names>M</given-names></name><name><surname>Reitman</surname><given-names>M</given-names></name><name><surname>Weinstein</surname><given-names>L</given-names></name></person-group><article-title>Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism</article-title><source>J. Clin. Invest</source><year>2000</year><volume>105</volume><fpage>615</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">10712433</pub-id></citation></ref><ref id="R79"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Haluzik</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>NJ</given-names></name><name><surname>Lorenzo</surname><given-names>J</given-names></name><name><surname>Dietz</surname><given-names>KR</given-names></name><name><surname>Reitman</surname><given-names>ML</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance</article-title><source>Endocrinology</source><year>2004</year><volume>145</volume><issue>9</issue><fpage>4094</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">15166122</pub-id></citation></ref><ref id="R80"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skinner</surname><given-names>J</given-names></name><name><surname>Cattanach</surname><given-names>B</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name></person-group><article-title>The imprinted oedematous-small mutation on mouse chromosome 2 identifies new roles for gnas and gnasxl in development</article-title><source>Genomics</source><year>2002</year><volume>80</volume><issue>4</issue><fpage>373</fpage><pub-id pub-id-type="pmid">12376090</pub-id></citation></ref><ref id="R81"><label>81</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>CM</given-names></name><name><surname>Ball</surname><given-names>ST</given-names></name><name><surname>Nottingham</surname><given-names>WT</given-names></name><name><surname>Skinner</surname><given-names>JA</given-names></name><name><surname>Plagge</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>MD</given-names></name><name><surname>Powles</surname><given-names>N</given-names></name><name><surname>Hough</surname><given-names>T</given-names></name><name><surname>Papworth</surname><given-names>D</given-names></name><name><surname>Fraser</surname><given-names>WD</given-names></name><name><surname>Maconochie</surname><given-names>M</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name></person-group><article-title>A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas</article-title><source>Nat. Genet</source><year>2004</year><volume>36</volume><issue>8</issue><fpage>894</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15273687</pub-id></citation></ref><ref id="R82"><label>82</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>AT</given-names></name><name><surname>Nackers</surname><given-names>LM</given-names></name><name><surname>Lorenzo</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Alternative Gnas gene products have opposite effects on glucose and lipid metabolism</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>2005</year><volume>102</volume><issue>20</issue><fpage>7386</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15883378</pub-id></citation></ref><ref id="R83"><label>83</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Genevieve</surname><given-names>D</given-names></name><name><surname>Sanlaville</surname><given-names>D</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Kottler</surname><given-names>ML</given-names></name><name><surname>Jambou</surname><given-names>M</given-names></name><name><surname>Gosset</surname><given-names>P</given-names></name><name><surname>Boustani-Samara</surname><given-names>D</given-names></name><name><surname>Pinto</surname><given-names>G</given-names></name><name><surname>Ozilou</surname><given-names>C</given-names></name><name><surname>Abeguile</surname><given-names>G</given-names></name><name><surname>Munnich</surname><given-names>A</given-names></name><name><surname>Romana</surname><given-names>S</given-names></name><name><surname>Raoul</surname><given-names>O</given-names></name><name><surname>Cormier-Daire</surname><given-names>V</given-names></name><name><surname>Vekemans</surname><given-names>M</given-names></name></person-group><article-title>Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and postnatal growth retardation and intractable feeding difficulties</article-title><source>Eur. J. Hum. Genet</source><year>2005</year><volume>13</volume><issue>9</issue><fpage>1033</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15915160</pub-id></citation></ref><ref id="R84"><label>84</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Agarwal</surname><given-names>N</given-names></name><name><surname>Gruen</surname><given-names>JR</given-names></name><name><surname>Bick</surname><given-names>D</given-names></name><name><surname>Weissman</surname><given-names>SM</given-names></name></person-group><article-title>Differential expression of novel Gs alpha signal transduction protein cDNA species</article-title><source>Nucleic Acids Res</source><year>1991</year><volume>19</volume><issue>17</issue><fpage>4725</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1716359</pub-id></citation></ref><ref id="R85"><label>85</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Litman</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Weinstein</surname><given-names>L</given-names></name></person-group><article-title>Identification of a methylation imprint mark within the mouse gnas locus</article-title><source>Mol. Cell Biol</source><year>2000</year><volume>20</volume><fpage>5808</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10913164</pub-id></citation></ref><ref id="R86"><label>86</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Bianchi</surname><given-names>C</given-names></name><name><surname>Nadal-Ginard</surname><given-names>B</given-names></name><name><surname>Homcy</surname><given-names>CJ</given-names></name></person-group><article-title>Alternative promoter and 5' exon generate a novel G<sub>s</sub>&#x003b1; mRNA</article-title><source>J. Biol. Chem</source><year>1990</year><volume>265</volume><fpage>8458</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2111318</pub-id></citation></ref><ref id="R87"><label>87</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Vu</surname><given-names>TH</given-names></name><name><surname>Ulaner</surname><given-names>GA</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>JF</given-names></name><name><surname>Hoffman</surname><given-names>AR</given-names></name></person-group><article-title>Activating and silencing histone modifications form independent allelic switch regions in the imprinted Gnas gene</article-title><source>Hum. Mol. Genet</source><year>2004</year><volume>13</volume><issue>7</issue><fpage>741</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">14962976</pub-id></citation></ref><ref id="R88"><label>88</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Bourc'his</surname><given-names>D</given-names></name><name><surname>Nealon</surname><given-names>JG</given-names></name><name><surname>Erlichman</surname><given-names>B</given-names></name><name><surname>Bestor</surname><given-names>TH</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Identification of the control region for tissue-specific imprinting of the stimulatory G protein alpha-subunit</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>2005</year><volume>102</volume><issue>15</issue><fpage>5513</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15811946</pub-id></citation></ref><ref id="R89"><label>89</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Pincus</surname><given-names>JE</given-names></name><name><surname>Sugimoto</surname><given-names>T</given-names></name><name><surname>Tojo</surname><given-names>K</given-names></name><name><surname>Kanatani</surname><given-names>M</given-names></name><name><surname>Azuma</surname><given-names>Y</given-names></name><name><surname>Kruse</surname><given-names>K</given-names></name><name><surname>Rosenbloom</surname><given-names>AL</given-names></name><name><surname>Koshiyama</surname><given-names>H</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted <italic>GNAS1</italic> locus</article-title><source>Hum. Mol. Genet</source><year>2001</year><volume>10</volume><fpage>1231</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">11406605</pub-id></citation></ref><ref id="R90"><label>90</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Lane</surname><given-names>AH</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Paternal uniparental isodisomy of chromosome 20q (patUPD20q) - and the resulting changes in <italic>GNAS1</italic> methylation - as a plausible cause of pseudohypoparathyroidism</article-title><source>Am. J. Hum. Genet</source><year>2001</year><volume>68</volume><fpage>1283</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11294659</pub-id></citation></ref><ref id="R91"><label>91</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>AC</given-names></name><name><surname>Felsenfeld</surname><given-names>G</given-names></name></person-group><article-title>Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene</article-title><source>Nature</source><year>2000</year><volume>405</volume><issue>6785</issue><fpage>482</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10839546</pub-id></citation></ref><ref id="R92"><label>92</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hark</surname><given-names>AT</given-names></name><name><surname>Schoenherr</surname><given-names>CJ</given-names></name><name><surname>Katz</surname><given-names>DJ</given-names></name><name><surname>Ingram</surname><given-names>RS</given-names></name><name><surname>Levorse</surname><given-names>JM</given-names></name><name><surname>Tilghman</surname><given-names>SM</given-names></name></person-group><article-title>CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus</article-title><source>Nature</source><year>2000</year><volume>405</volume><issue>6785</issue><fpage>486</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10839547</pub-id></citation></ref><ref id="R93"><label>93</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>B</given-names></name><name><surname>Bonthron</surname><given-names>D</given-names></name></person-group><article-title>An imprinted antisense transcript at the human GNAS1 locus</article-title><source>Hum. Mol. Genet</source><year>2000</year><volume>9</volume><fpage>835</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">10749992</pub-id></citation></ref><ref id="R94"><label>94</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wroe</surname><given-names>SF</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Skinner</surname><given-names>JA</given-names></name><name><surname>Bodle</surname><given-names>D</given-names></name><name><surname>Ball</surname><given-names>ST</given-names></name><name><surname>Beechey</surname><given-names>CV</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Williamson</surname><given-names>CM</given-names></name></person-group><article-title>An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>2000</year><volume>97</volume><fpage>3342</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10716699</pub-id></citation></ref><ref id="R95"><label>95</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coombes</surname><given-names>C</given-names></name><name><surname>Arnaud</surname><given-names>P</given-names></name><name><surname>Gordon</surname><given-names>E</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Coar</surname><given-names>EA</given-names></name><name><surname>Williamson</surname><given-names>CM</given-names></name><name><surname>Feil</surname><given-names>R</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name></person-group><article-title>Epigenetic properties and identification of an imprint mark in the Nesp-Gnasxl domain of the mouse Gnas imprinted locus</article-title><source>Mol. Cell Biol</source><year>2003</year><volume>23</volume><issue>16</issue><fpage>5475</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">12897124</pub-id></citation></ref><ref id="R96"><label>96</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>CM</given-names></name><name><surname>Turner</surname><given-names>MD</given-names></name><name><surname>Ball</surname><given-names>ST</given-names></name><name><surname>Nottingham</surname><given-names>WT</given-names></name><name><surname>Glenister</surname><given-names>P</given-names></name><name><surname>Fray</surname><given-names>M</given-names></name><name><surname>Tymowska-Lalanne</surname><given-names>Z</given-names></name><name><surname>Plagge</surname><given-names>A</given-names></name><name><surname>Powles-Glover</surname><given-names>N</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Maconochie</surname><given-names>M</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name></person-group><article-title>Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster</article-title><source>Nat. Genet</source><year>2006</year><volume>38</volume><fpage>350</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16462745</pub-id></citation></ref><ref id="R97"><label>97</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>J</given-names></name><name><surname>Landis</surname><given-names>CA</given-names></name><name><surname>Harsh</surname><given-names>G</given-names></name><name><surname>Vallar</surname><given-names>L</given-names></name><name><surname>Grunewald</surname><given-names>K</given-names></name><name><surname>Feichtinger</surname><given-names>H</given-names></name><name><surname>Duh</surname><given-names>QY</given-names></name><name><surname>Clark</surname><given-names>OH</given-names></name><name><surname>Kawasaki</surname><given-names>E</given-names></name><name><surname>Bourne</surname><given-names>HR</given-names></name><etal/></person-group><article-title>Two G protein oncogenes in human endocrine tumors</article-title><source>Science</source><year>1990</year><volume>249</volume><issue>4969</issue><fpage>655</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2116665</pub-id></citation></ref><ref id="R98"><label>98</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Warner</surname><given-names>DR</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Endocrine Manifestations of Stimulatory G Protein alpha-Subunit Mutations and the Role of Genomic Imprinting</article-title><source>Endocr. Rev</source><year>2001</year><volume>22</volume><issue>5</issue><fpage>675</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">11588148</pub-id></citation></ref><ref id="R99"><label>99</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fragoso</surname><given-names>MC</given-names></name><name><surname>Latronico</surname><given-names>AC</given-names></name><name><surname>Carvalho</surname><given-names>FM</given-names></name><name><surname>Zerbini</surname><given-names>MC</given-names></name><name><surname>Marcondes</surname><given-names>JA</given-names></name><name><surname>Araujo</surname><given-names>LM</given-names></name><name><surname>Lando</surname><given-names>VS</given-names></name><name><surname>Frazzatto</surname><given-names>ET</given-names></name><name><surname>Mendonca</surname><given-names>BB</given-names></name><name><surname>Villares</surname><given-names>SM</given-names></name></person-group><article-title>Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors</article-title><source>J. Clin. Endocrinol. Metab</source><year>1998</year><volume>83</volume><issue>6</issue><fpage>2074</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9626141</pub-id></citation></ref><ref id="R100"><label>100</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalfa</surname><given-names>N</given-names></name><name><surname>Ecochard</surname><given-names>A</given-names></name><name><surname>Patte</surname><given-names>C</given-names></name><name><surname>Duvillard</surname><given-names>P</given-names></name><name><surname>Audran</surname><given-names>F</given-names></name><name><surname>Pienkowski</surname><given-names>C</given-names></name><name><surname>Thibaud</surname><given-names>E</given-names></name><name><surname>Brauner</surname><given-names>R</given-names></name><name><surname>Lecointre</surname><given-names>C</given-names></name><name><surname>Plantaz</surname><given-names>D</given-names></name><name><surname>Guedj</surname><given-names>AM</given-names></name><name><surname>Paris</surname><given-names>F</given-names></name><name><surname>Baldet</surname><given-names>P</given-names></name><name><surname>Lumbroso</surname><given-names>S</given-names></name><name><surname>Sultan</surname><given-names>C</given-names></name></person-group><article-title>Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor?</article-title><source>J. Clin. Endocrinol. Metab</source><year>2006</year><volume>91</volume><issue>5</issue><fpage>1842</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16507630</pub-id></citation></ref><ref id="R101"><label>101</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalfa</surname><given-names>N</given-names></name><name><surname>Lumbroso</surname><given-names>S</given-names></name><name><surname>Boulle</surname><given-names>N</given-names></name><name><surname>Guiter</surname><given-names>J</given-names></name><name><surname>Soustelle</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>P</given-names></name><name><surname>Chapuis</surname><given-names>H</given-names></name><name><surname>Baldet</surname><given-names>P</given-names></name><name><surname>Sultan</surname><given-names>C</given-names></name></person-group><article-title>Activating mutations of Gsalpha in kidney cancer</article-title><source>J. Urol</source><year>2006</year><volume>176</volume><issue>3</issue><fpage>891</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16890646</pub-id></citation></ref><ref id="R102"><label>102</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeiger</surname><given-names>MA</given-names></name><name><surname>Saji</surname><given-names>M</given-names></name><name><surname>Gusev</surname><given-names>Y</given-names></name><name><surname>Westra</surname><given-names>WH</given-names></name><name><surname>Takiyama</surname><given-names>Y</given-names></name><name><surname>Dooley</surname><given-names>WC</given-names></name><name><surname>Kohn</surname><given-names>LD</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice</article-title><source>Endocrinology</source><year>1997</year><volume>138</volume><issue>8</issue><fpage>3133</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">9231760</pub-id></citation></ref><ref id="R103"><label>103</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muca</surname><given-names>C</given-names></name><name><surname>Vallar</surname><given-names>L</given-names></name></person-group><article-title>Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells</article-title><source>Oncogene</source><year>1994</year><volume>9</volume><issue>12</issue><fpage>3647</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">7526317</pub-id></citation></ref><ref id="R104"><label>104</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>D</given-names></name><name><surname>Magalon</surname><given-names>K</given-names></name><name><surname>Pertuit</surname><given-names>M</given-names></name><name><surname>Rasolonjanahary</surname><given-names>R</given-names></name><name><surname>Barlier</surname><given-names>A</given-names></name><name><surname>Enjalbert</surname><given-names>A</given-names></name><name><surname>Gerard</surname><given-names>C</given-names></name></person-group><article-title>Conditional overexpression of the wild-type Gs alpha as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><issue>6</issue><fpage>2973</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">17363453</pub-id></citation></ref><ref id="R105"><label>105</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCune</surname><given-names>D</given-names></name></person-group><article-title>Osteitis fibrosa cystica; the case of a nine-year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism</article-title><source>Am. J. Dis. Child</source><year>1936</year><volume>52</volume><fpage>743</fpage><lpage>4</lpage></citation></ref><ref id="R106"><label>106</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albright</surname><given-names>F</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hampton</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name></person-group><article-title>Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females</article-title><source>New Engl. J. Med</source><year>1937</year><volume>216</volume><fpage>727</fpage><lpage>46</lpage></citation></ref><ref id="R107"><label>107</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Shenker</surname><given-names>A</given-names></name><name><surname>Gejman</surname><given-names>PV</given-names></name><name><surname>Merino</surname><given-names>MJ</given-names></name><name><surname>Friedman</surname><given-names>E</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>Activating mutations of the stimulatory G protein in the McCune-Albright syndrome</article-title><source>New Engl. J. Med</source><year>1991</year><volume>325</volume><fpage>1688</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">1944469</pub-id></citation></ref><ref id="R108"><label>108</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwindinger</surname><given-names>WF</given-names></name><name><surname>Francomano</surname><given-names>CA</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1992</year><volume>89</volume><issue>11</issue><fpage>5152</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1594625</pub-id></citation></ref><ref id="R109"><label>109</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Happle</surname><given-names>R</given-names></name></person-group><article-title>The McCune-Albright syndrome: a lethal gene surviving by mosaicism</article-title><source>Clin. Genet</source><year>1986</year><volume>29</volume><issue>4</issue><fpage>321</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3720010</pub-id></citation></ref><ref id="R110"><label>110</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>P</given-names></name><name><surname>Riminucci</surname><given-names>M</given-names></name><name><surname>Majolagbe</surname><given-names>A</given-names></name><name><surname>Kuznetsov</surname><given-names>SA</given-names></name><name><surname>Collins</surname><given-names>MT</given-names></name><name><surname>Mankani</surname><given-names>MH</given-names></name><name><surname>Corsi</surname><given-names>A</given-names></name><name><surname>Bone</surname><given-names>HG</given-names></name><name><surname>Wientroub</surname><given-names>S</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name><name><surname>Fisher</surname><given-names>LW</given-names></name><name><surname>Robey</surname><given-names>PG</given-names></name></person-group><article-title>Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone</article-title><source>J. Bone Miner. Res</source><year>2000</year><volume>15</volume><issue>1</issue><fpage>120</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10646121</pub-id></citation></ref><ref id="R111"><label>111</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shenker</surname><given-names>A</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Sweet</surname><given-names>DE</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome</article-title><source>J. Clin. Endocrinol. Metab</source><year>1994</year><volume>79</volume><issue>3</issue><fpage>750</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8077356</pub-id></citation></ref><ref id="R112"><label>112</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Idowu</surname><given-names>BD</given-names></name><name><surname>Al-Adnani</surname><given-names>M</given-names></name><name><surname>O'Donnell</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Odell</surname><given-names>E</given-names></name><name><surname>Diss</surname><given-names>T</given-names></name><name><surname>Gale</surname><given-names>RE</given-names></name><name><surname>Flanagan</surname><given-names>AM</given-names></name></person-group><article-title>A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone</article-title><source>Histopathology</source><year>2007</year><volume>50</volume><issue>6</issue><fpage>691</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">17493233</pub-id></citation></ref><ref id="R113"><label>113</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danon</surname><given-names>M</given-names></name><name><surname>Crawford</surname><given-names>JD</given-names></name></person-group><article-title>The McCune-Albright syndrome</article-title><source>Ergeb. Inn. Med. Kinderheilkd</source><year>1987</year><volume>55</volume><fpage>81</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">3545811</pub-id></citation></ref><ref id="R114"><label>114</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mauras</surname><given-names>N</given-names></name><name><surname>Blizzard</surname><given-names>RM</given-names></name></person-group><article-title>The McCune-Albright syndrome</article-title><source>Acta Endocrinol Suppl. (Copenh)</source><year>1986</year><volume>279</volume><fpage>207</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">3465162</pub-id></citation></ref><ref id="R115"><label>115</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kovacs</surname><given-names>K</given-names></name><name><surname>Horvath</surname><given-names>E</given-names></name><name><surname>Thorner</surname><given-names>MO</given-names></name><name><surname>Rogol</surname><given-names>AD</given-names></name></person-group><article-title>Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis</article-title><source>Virchows Arch. A. Pathol. Anat. Histopathol</source><year>1984</year><volume>403</volume><issue>1</issue><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">6426154</pub-id></citation></ref><ref id="R116"><label>116</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Imanishi</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>E</given-names></name><name><surname>Nakagomi</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Miyauchi</surname><given-names>A</given-names></name><name><surname>Satomura</surname><given-names>K</given-names></name><name><surname>Koshiyama</surname><given-names>H</given-names></name><name><surname>Inaba</surname><given-names>M</given-names></name><name><surname>Nishizawa</surname><given-names>Y</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Ozono</surname><given-names>K</given-names></name></person-group><article-title>The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome</article-title><source>J. Bone Miner. Metab</source><year>2005</year><volume>23</volume><issue>3</issue><fpage>231</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15838626</pub-id></citation></ref><ref id="R117"><label>117</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Imanishi</surname><given-names>Y</given-names></name><name><surname>Koshiyama</surname><given-names>H</given-names></name><name><surname>Miyauchi</surname><given-names>A</given-names></name><name><surname>Wakasa</surname><given-names>K</given-names></name><name><surname>Kawata</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>H</given-names></name><name><surname>Ohashi</surname><given-names>H</given-names></name><name><surname>Koyano</surname><given-names>HM</given-names></name><name><surname>Mochizuki</surname><given-names>R</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Inaba</surname><given-names>M</given-names></name><name><surname>Nishizawa</surname><given-names>Y</given-names></name></person-group><article-title>Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia</article-title><source>Life Sci</source><year>2006</year><volume>78</volume><issue>20</issue><fpage>2295</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">16337659</pub-id></citation></ref><ref id="R118"><label>118</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riminucci</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>MT</given-names></name><name><surname>Fedarko</surname><given-names>NS</given-names></name><name><surname>Cherman</surname><given-names>N</given-names></name><name><surname>Corsi</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>KE</given-names></name><name><surname>Waguespack</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Hannon</surname><given-names>T</given-names></name><name><surname>Econs</surname><given-names>MJ</given-names></name><name><surname>Bianco</surname><given-names>P</given-names></name><name><surname>Gehron Robey</surname><given-names>P</given-names></name></person-group><article-title>FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting</article-title><source>J. Clin. Invest</source><year>2003</year><volume>112</volume><issue>5</issue><fpage>683</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">12952917</pub-id></citation></ref><ref id="R119"><label>119</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albright</surname><given-names>F</given-names></name><name><surname>Burnett</surname><given-names>CH</given-names></name><name><surname>Smith</surname><given-names>PH</given-names></name><name><surname>Parson</surname><given-names>W</given-names></name></person-group><article-title>Pseudohypoparathyroidism - an example of "Seabright-Bantam syndrome"</article-title><source>Endocrinology</source><year>1942</year><volume>30</volume><fpage>922</fpage><lpage>32</lpage></citation></ref><ref id="R120"><label>120</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Abou-Samra</surname><given-names>AB</given-names></name><name><surname>Freeman</surname><given-names>MW</given-names></name><name><surname>Kong</surname><given-names>XF</given-names></name><name><surname>Schipani</surname><given-names>E</given-names></name><name><surname>Richards</surname><given-names>J</given-names></name><name><surname>Kolakowski LF</surname><given-names>Jr</given-names></name><name><surname>Hock</surname><given-names>J</given-names></name><name><surname>Potts JT</surname><given-names>Jr</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Segre</surname><given-names>GV</given-names></name></person-group><article-title>AG protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide</article-title><source>Science</source><year>1991</year><volume>254</volume><fpage>1024</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1658941</pub-id></citation></ref><ref id="R121"><label>121</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abou-Samra</surname><given-names>AB</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Force</surname><given-names>T</given-names></name><name><surname>Freeman</surname><given-names>MW</given-names></name><name><surname>Kong</surname><given-names>XF</given-names></name><name><surname>Schipani</surname><given-names>E</given-names></name><name><surname>Urena</surname><given-names>P</given-names></name><name><surname>Richards</surname><given-names>J</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Potts JT</surname><given-names>Jr</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Segre</surname><given-names>GV</given-names></name></person-group><article-title>Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1992</year><volume>89</volume><fpage>2732</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1313566</pub-id></citation></ref><ref id="R122"><label>122</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>JT</given-names></name></person-group><article-title>Parathyroid hormone: past and present</article-title><source>J. Endocrinol</source><year>2005</year><volume>187</volume><issue>3</issue><fpage>311</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16423810</pub-id></citation></ref><ref id="R123"><label>123</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gensure</surname><given-names>RC</given-names></name><name><surname>Gardella</surname><given-names>TJ</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Parathyroid hormone and parathyroid hormone-related peptide, and their receptors</article-title><source>Biochem Biophys. Res. Commun</source><year>2005</year><volume>328</volume><issue>3</issue><fpage>666</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">15694400</pub-id></citation></ref><ref id="R124"><label>124</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellsworth</surname><given-names>R</given-names></name><name><surname>Howard</surname><given-names>JE</given-names></name></person-group><article-title>Studies on the physiology of the parathyroid glands. VII.Some responses of normal human kidneys and blood to intravenous parathyroid extract</article-title><source>Bull Johns Hopkins Hosp</source><year>1934</year><volume>55</volume><fpage>296</fpage></citation></ref><ref id="R125"><label>125</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chase</surname><given-names>LR</given-names></name><name><surname>Melson</surname><given-names>GL</given-names></name><name><surname>Aurbach</surname><given-names>GD</given-names></name></person-group><article-title>Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone</article-title><source>J. Clin. Invest</source><year>1969</year><volume>48</volume><fpage>1832</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">4309802</pub-id></citation></ref><ref id="R126"><label>126</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Ahn</surname><given-names>TG</given-names></name><name><surname>Klupt</surname><given-names>SF</given-names></name><name><surname>Kaufman</surname><given-names>KD</given-names></name><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Bourne</surname><given-names>HR</given-names></name><name><surname>Sullivan</surname><given-names>KA</given-names></name><name><surname>Van Dop</surname><given-names>C</given-names></name></person-group><article-title>Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1988</year><volume>85</volume><issue>2</issue><fpage>617</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">2829196</pub-id></citation></ref><ref id="R127"><label>127</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patten</surname><given-names>JL</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Immunochemical analysis of the &#x003b1;-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy</article-title><source>J. Clin. Endocrinol. Metab</source><year>1990</year><volume>71</volume><fpage>1208</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">2121768</pub-id></citation></ref><ref id="R128"><label>128</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>A</given-names></name><name><surname>Bardin</surname><given-names>C</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Simons</surname><given-names>C</given-names></name><name><surname>Bray</surname><given-names>P</given-names></name><name><surname>Spiegel</surname><given-names>A</given-names></name></person-group><article-title>Reduced expression of multiple forms of the &#x003b1;subunit of the stimulatory GTP-binding protein in pseudohypoparathyroidism type Ia</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1987</year><volume>84</volume><fpage>7266</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2890163</pub-id></citation></ref><ref id="R129"><label>129</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Gejman</surname><given-names>PV</given-names></name><name><surname>Friedman</surname><given-names>E</given-names></name><name><surname>Kadowaki</surname><given-names>T</given-names></name><name><surname>Collins</surname><given-names>RM</given-names></name><name><surname>Gershon</surname><given-names>ES</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis</article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>1990</year><volume>87</volume><issue>21</issue><fpage>8287</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">2122458</pub-id></citation></ref><ref id="R130"><label>130</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patten</surname><given-names>JL</given-names></name><name><surname>Johns</surname><given-names>DR</given-names></name><name><surname>Valle</surname><given-names>D</given-names></name><name><surname>Eil</surname><given-names>C</given-names></name><name><surname>Gruppuso</surname><given-names>PA</given-names></name><name><surname>Steele</surname><given-names>G</given-names></name><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy</article-title><source>New Engl. J. Med</source><year>1990</year><volume>322</volume><fpage>1412</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2109828</pub-id></citation></ref><ref id="R131"><label>131</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Downs RW</surname><given-names>Jr</given-names></name><name><surname>Moses</surname><given-names>AM</given-names></name><name><surname>Breslau</surname><given-names>NA</given-names></name><name><surname>Marx</surname><given-names>SJ</given-names></name><name><surname>Lasker</surname><given-names>RD</given-names></name><name><surname>Rizzoli</surname><given-names>RE</given-names></name><name><surname>Aurbach</surname><given-names>GD</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein</article-title><source>Am. J. Med</source><year>1983</year><volume>74</volume><fpage>545</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">6301273</pub-id></citation></ref><ref id="R132"><label>132</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mallet</surname><given-names>E</given-names></name><name><surname>Carayon</surname><given-names>P</given-names></name><name><surname>Amr</surname><given-names>S</given-names></name><name><surname>Brunelle</surname><given-names>P</given-names></name><name><surname>Ducastelle</surname><given-names>T</given-names></name><name><surname>Basuyau</surname><given-names>JP</given-names></name><name><surname>de Menibus</surname><given-names>CH</given-names></name></person-group><article-title>Coupling defect of thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient</article-title><source>J. Clin. Endocrinol. Metab</source><year>1982</year><volume>54</volume><issue>5</issue><fpage>1028</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">6277985</pub-id></citation></ref><ref id="R133"><label>133</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolfsdorf</surname><given-names>JI</given-names></name><name><surname>Rosenfield</surname><given-names>RL</given-names></name><name><surname>Fang</surname><given-names>VS</given-names></name><name><surname>Kobayashi</surname><given-names>R</given-names></name><name><surname>Razdan</surname><given-names>AK</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name></person-group><article-title>Partial gonadotrophin-resistance in pseudohypoparathyroidism</article-title><source>Acta Endocrinol. (Copenh)</source><year>1978</year><volume>88</volume><issue>2</issue><fpage>321</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">208340</pub-id></citation></ref><ref id="R134"><label>134</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>G</given-names></name><name><surname>Maghnie</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>G</given-names></name><name><surname>De Menis</surname><given-names>E</given-names></name><name><surname>Brunelli</surname><given-names>V</given-names></name><name><surname>Cappa</surname><given-names>M</given-names></name><name><surname>Loli</surname><given-names>P</given-names></name><name><surname>Beck-Peccoz</surname><given-names>P</given-names></name><name><surname>Spada</surname><given-names>A</given-names></name></person-group><article-title>Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene</article-title><source>J. Clin. Endocrinol. Metab</source><year>2003</year><volume>88</volume><issue>9</issue><fpage>4070</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12970263</pub-id></citation></ref><ref id="R135"><label>135</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Germain-Lee</surname><given-names>EL</given-names></name><name><surname>Groman</surname><given-names>J</given-names></name><name><surname>Crane</surname><given-names>JL</given-names></name><name><surname>Jan de Beur</surname><given-names>SM</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance</article-title><source>J. Clin. Endocrinol. Metab</source><year>2003</year><volume>88</volume><issue>9</issue><fpage>4059</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">12970262</pub-id></citation></ref><ref id="R136"><label>136</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faull</surname><given-names>CM</given-names></name><name><surname>Welbury</surname><given-names>RR</given-names></name><name><surname>Paul</surname><given-names>B</given-names></name><name><surname>Kendall-Taylor</surname><given-names>P</given-names></name></person-group><article-title>Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family</article-title><source>Q. J. Med</source><year>1991</year><volume>78</volume><issue>287</issue><fpage>251</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">2047519</pub-id></citation></ref><ref id="R137"><label>137</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moses</surname><given-names>AM</given-names></name><name><surname>Weinstock</surname><given-names>RS</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Breslau</surname><given-names>NA</given-names></name></person-group><article-title>Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient pseudohypoparathyroidism</article-title><source>J. Clin. Endocrinol. Metab</source><year>1986</year><volume>62</volume><fpage>221</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">2999179</pub-id></citation></ref><ref id="R138"><label>138</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>KS</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Wu</surname><given-names>DJ</given-names></name><name><surname>Huang</surname><given-names>TS</given-names></name><name><surname>Tsai</surname><given-names>IH</given-names></name><name><surname>Chen</surname><given-names>FW</given-names></name></person-group><article-title>Deficient erythrocyte membrane Gs alpha activity and resistance to trophic hormones of multiple endocrine organs in two cases of pseudohypoparathyroidism</article-title><source>Taiwan Yi Xue Hui Za Zhi</source><year>1989</year><volume>88</volume><issue>5</issue><fpage>450</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2507735</pub-id></citation></ref><ref id="R139"><label>139</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albright</surname><given-names>F</given-names></name><name><surname>Forbes</surname><given-names>AP</given-names></name><name><surname>Henneman</surname><given-names>PH</given-names></name></person-group><article-title>Pseudo-pseudohypo-parathyroidism</article-title><source>Trans. Assoc. Am. Physicians</source><year>1952</year><volume>65</volume><fpage>337</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">13005676</pub-id></citation></ref><ref id="R140"><label>140</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Jap</surname><given-names>TS</given-names></name><name><surname>Mauseth RS</surname><given-names>RS</given-names></name><name><surname>Downs</surname><given-names>J</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudohypoparathyroidism: Biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds</article-title><source>J. Clin. Endocrinol. Metab</source><year>1986</year><volume>62</volume><fpage>497</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">3003142</pub-id></citation></ref><ref id="R141"><label>141</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>AJ</given-names></name><name><surname>Hughes</surname><given-names>HE</given-names></name></person-group><article-title>Imprinting in Albright's hereditary osteodystrophy</article-title><source>J Med Genet</source><year>1993</year><volume>30</volume><fpage>101</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8383205</pub-id></citation></ref><ref id="R142"><label>142</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>LC</given-names></name><name><surname>Oude-Luttikhuis</surname><given-names>MEM</given-names></name><name><surname>Clayton</surname><given-names>PT</given-names></name><name><surname>Fraser</surname><given-names>WD</given-names></name><name><surname>Trembath</surname><given-names>RC</given-names></name></person-group><article-title>Parental origin of Gs&#x003b1; gene mutations in Albright's hereditary osteodystrophy</article-title><source>J. Med. Genet</source><year>1994</year><volume>31</volume><fpage>835</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7853365</pub-id></citation></ref><ref id="R143"><label>143</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Kawaguchi</surname><given-names>H</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Chung</surname><given-names>UI</given-names></name></person-group><article-title>Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage <italic>in vivo</italic></article-title><source>Proc. Natl. Acad. Sci. U.S.A</source><year>2004</year><volume>101</volume><issue>41</issue><fpage>14794</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15459318</pub-id></citation></ref><ref id="R144"><label>144</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>DN</given-names></name><name><surname>McGuire</surname><given-names>S</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Germain-Lee</surname><given-names>EL</given-names></name></person-group><article-title>Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity</article-title><source>J. Clin. Endocrinol. Metab</source><year>2007</year><volume>92</volume><issue>3</issue><fpage>1073</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17164301</pub-id></citation></ref><ref id="R145"><label>145</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>FS</given-names></name><name><surname>Shore</surname><given-names>EM</given-names></name></person-group><article-title>Progressive osseous heteroplasia</article-title><source>J. Bone Miner. Res</source><year>2000</year><volume>15</volume><issue>11</issue><fpage>2084</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11092391</pub-id></citation></ref><ref id="R146"><label>146</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>MC</given-names></name><name><surname>De Beur</surname><given-names>SM</given-names></name><name><surname>Yandow</surname><given-names>SM</given-names></name><name><surname>McAlister</surname><given-names>WH</given-names></name><name><surname>Shore</surname><given-names>EM</given-names></name><name><surname>Kaplan</surname><given-names>FS</given-names></name><name><surname>Whyte</surname><given-names>MP</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification</article-title><source>J Bone Miner. Res</source><year>2000</year><volume>15</volume><issue>11</issue><fpage>2074</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11092390</pub-id></citation></ref><ref id="R147"><label>147</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shore</surname><given-names>EM</given-names></name><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Jan de Beur</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Gardner</surname><given-names>RJ</given-names></name><name><surname>Zasloff</surname><given-names>MA</given-names></name><name><surname>Whyte</surname><given-names>MP</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name><name><surname>Kaplan</surname><given-names>FS</given-names></name></person-group><article-title>Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia</article-title><source>N. Engl. J. Med</source><year>2002</year><volume>346</volume><issue>2</issue><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">11784876</pub-id></citation></ref><ref id="R148"><label>148</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>SF</given-names></name><name><surname>Barr</surname><given-names>DG</given-names></name><name><surname>Bonthron</surname><given-names>DT</given-names></name></person-group><article-title>GNAS1 mutations and progressive osseous heteroplasia</article-title><source>N. Engl. J. Med</source><year>2002</year><volume>346</volume><issue>21</issue><fpage>1669</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12024004</pub-id></citation></ref><ref id="R149"><label>149</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>RA</given-names></name><name><surname>Shore</surname><given-names>EM</given-names></name><name><surname>Stevens</surname><given-names>CE</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Phillips</surname><given-names>CD</given-names></name><name><surname>Kaplan</surname><given-names>FS</given-names></name></person-group><article-title>Progressive osseous heteroplasia in the face of a child</article-title><source>Am. J. Med. Genet. A</source><year>2003</year><volume>118</volume><issue>1</issue><fpage>71</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12605446</pub-id></citation></ref><ref id="R150"><label>150</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>I</given-names></name><name><surname>Hamada</surname><given-names>T</given-names></name><name><surname>Hardman</surname><given-names>C</given-names></name><name><surname>McGrath</surname><given-names>JA</given-names></name><name><surname>Child</surname><given-names>FJ</given-names></name></person-group><article-title>Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene</article-title><source>Clin. Exp. Dermatol</source><year>2004</year><volume>29</volume><issue>1</issue><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">14723729</pub-id></citation></ref><ref id="R151"><label>151</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Erlichman</surname><given-names>B</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>The stimulatory G protein &#x003b1;-subunit Gs&#x003b1; is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B</article-title><source>J. Clin. Endocrinol. Metabol</source><year>2003</year><volume>88</volume><issue>9</issue><fpage>4336</fpage><lpage>41</lpage></citation></ref><ref id="R152"><label>152</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Nanclares</surname><given-names>GP</given-names></name><name><surname>Fernandez-Rebollo</surname><given-names>E</given-names></name><name><surname>Santin</surname><given-names>I</given-names></name><name><surname>Garcia-Cuartero</surname><given-names>B</given-names></name><name><surname>Gaztambide</surname><given-names>S</given-names></name><name><surname>Menendez</surname><given-names>E</given-names></name><name><surname>Morales</surname><given-names>MJ</given-names></name><name><surname>Pombo</surname><given-names>M</given-names></name><name><surname>Bilbao</surname><given-names>JR</given-names></name><name><surname>Barros</surname><given-names>F</given-names></name><name><surname>Zazo</surname><given-names>N</given-names></name><name><surname>Ahrens</surname><given-names>W</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Hiort</surname><given-names>O</given-names></name><name><surname>Castano</surname><given-names>L</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name></person-group><article-title>Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy</article-title><source>J. Clin. Endocrinol. Metab</source><year>2007</year><volume>92</volume><issue>6</issue><fpage>2370</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17405843</pub-id></citation></ref><ref id="R153"><label>153</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silve</surname><given-names>C</given-names></name><name><surname>Santora</surname><given-names>A</given-names></name><name><surname>Breslau</surname><given-names>N</given-names></name><name><surname>Moses</surname><given-names>A</given-names></name><name><surname>Spiegel</surname><given-names>A</given-names></name></person-group><article-title>Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib</article-title><source>J. Clin. Endocrinol. Metab</source><year>1986</year><volume>62</volume><fpage>640</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3005354</pub-id></citation></ref><ref id="R154"><label>154</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>WI</given-names></name><name><surname>Schwindinger</surname><given-names>WF</given-names></name><name><surname>Aparicio</surname><given-names>LF</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of G&#x003b1;s: A cause of pseudohypoparathyroidism type Ib</article-title><source>J. Biol. Chem</source><year>2001</year><volume>276</volume><issue>1</issue><fpage>165</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">11029463</pub-id></citation></ref><ref id="R155"><label>155</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schipani</surname><given-names>E</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name><name><surname>Bergwitz</surname><given-names>C</given-names></name><name><surname>Iida-Klein</surname><given-names>A</given-names></name><name><surname>Kong</surname><given-names>XF</given-names></name><name><surname>Stuhrmann</surname><given-names>M</given-names></name><name><surname>Kruse</surname><given-names>K</given-names></name><name><surname>Whyte</surname><given-names>MP</given-names></name><name><surname>Murray</surname><given-names>T</given-names></name><name><surname>Schmidtke</surname><given-names>J</given-names></name><name><surname>van Dop</surname><given-names>C</given-names></name><name><surname>Brickman</surname><given-names>AS</given-names></name><name><surname>Crawford</surname><given-names>JD</given-names></name><name><surname>Potts JT</surname><given-names>Jr</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Abou-Samra</surname><given-names>AB</given-names></name><name><surname>Segre</surname><given-names>GV</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene</article-title><source>J. Clin. Endocrinol. Metab</source><year>1995</year><volume>80</volume><fpage>1611</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">7745008</pub-id></citation></ref><ref id="R156"><label>156</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukumoto</surname><given-names>S</given-names></name><name><surname>Suzawa</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>Y</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Kodama</surname><given-names>Y</given-names></name><name><surname>Ogata</surname><given-names>E</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name></person-group><article-title>Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib</article-title><source>J. Clin. Endocrinol. Metab</source><year>1996</year><volume>81</volume><fpage>2554</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8675577</pub-id></citation></ref><ref id="R157"><label>157</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jan de Beur</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>LaBuda</surname><given-names>M</given-names></name><name><surname>Usdin</surname><given-names>T</given-names></name><name><surname>Levine</surname><given-names>M</given-names></name></person-group><article-title>Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes</article-title><source>J. Clin. Endocrinol. Metab</source><year>2000</year><volume>85</volume><fpage>2239</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">10852457</pub-id></citation></ref><ref id="R158"><label>158</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Schipani</surname><given-names>E</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Cole</surname><given-names>DEC</given-names></name><name><surname>Lawson</surname><given-names>ML</given-names></name><name><surname>Mannstadt</surname><given-names>M</given-names></name><name><surname>Hendy</surname><given-names>GN</given-names></name><name><surname>Plotkin</surname><given-names>H</given-names></name><name><surname>Koshiyama</surname><given-names>H</given-names></name><name><surname>Koh</surname><given-names>T</given-names></name><name><surname>Crawford</surname><given-names>JD</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name><name><surname>Vikkula</surname><given-names>M</given-names></name></person-group><article-title>The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3</article-title><source>. Proc. Natl. Acad. Sci. U.S.A</source><year>1998</year><volume>95</volume><fpage>11798</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">9751745</pub-id></citation></ref><ref id="R159"><label>159</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jan De Beur</surname><given-names>SM</given-names></name><name><surname>O'Connell</surname><given-names>JR</given-names></name><name><surname>Peila</surname><given-names>R</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Kam</surname><given-names>S</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>The pseudohypoparathyroidism type lb locus is linked to a region including GNAS1 at 20q13.3</article-title><source>. J. Bone Miner. Res</source><year>2003</year><volume>18</volume><issue>3</issue><fpage>424</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12619926</pub-id></citation></ref><ref id="R160"><label>160</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Fr&#x000f6;hlich</surname><given-names>LF</given-names></name><name><surname>Hendy</surname><given-names>GN</given-names></name><name><surname>Indridason</surname><given-names>OS</given-names></name><name><surname>Josse</surname><given-names>RG</given-names></name><name><surname>Koshiyama</surname><given-names>H</given-names></name><name><surname>Korkko</surname><given-names>J</given-names></name><name><surname>Nakamoto</surname><given-names>JM</given-names></name><name><surname>Rosenbloom</surname><given-names>AL</given-names></name><name><surname>Slyper</surname><given-names>AH</given-names></name><name><surname>Sugimoto</surname><given-names>T</given-names></name><name><surname>Tsatsoulis</surname><given-names>A</given-names></name><name><surname>Crawford</surname><given-names>JD</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS</article-title><source>J. Clin. Invest</source><year>2003</year><volume>112</volume><issue>8</issue><fpage>1255</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">14561710</pub-id></citation></ref><ref id="R161"><label>161</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahmud</surname><given-names>FH</given-names></name><name><surname>Linglart</surname><given-names>A</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Lteif</surname><given-names>AN</given-names></name></person-group><article-title>Molecular diagnosis of pseudohypoparathyroidism type Ib in a family with presumed paroxysmal dyskinesia</article-title><source>Pediatrics</source><year>2005</year><volume>115</volume><issue>2</issue><fpage>e242</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15629959</pub-id></citation></ref><ref id="R162"><label>162</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Nealon</surname><given-names>JG</given-names></name><name><surname>Weinstein</surname><given-names>LS</given-names></name></person-group><article-title>Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB</article-title><source>Hum. Mol. Genet</source><year>2005</year><volume>14</volume><issue>1</issue><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">15537666</pub-id></citation></ref><ref id="R163"><label>163</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laspa</surname><given-names>E</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Tsatsoulis</surname><given-names>A</given-names></name></person-group><article-title>Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance</article-title><source>J. Clin. Endocrinol. Metab</source><year>2004</year><volume>89</volume><issue>12</issue><fpage>5942</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15579741</pub-id></citation></ref><ref id="R164"><label>164</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linglart</surname><given-names>A</given-names></name><name><surname>Gensure</surname><given-names>RC</given-names></name><name><surname>Olney</surname><given-names>RC</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name></person-group><article-title>A Novel STX16 Deletion in Autosomal Dominant Pseudohypoparathyroidism Type Ib Redefines the Boundaries of a cis-Acting Imprinting Control Element of GNAS</article-title><source>Am. J. Hum. Genet</source><year>2005</year><volume>76</volume><issue>5</issue><fpage>804</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15800843</pub-id></citation></ref><ref id="R165"><label>165</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Fr&#x000f6;hlich</surname><given-names>LF</given-names></name><name><surname>Linglart</surname><given-names>A</given-names></name><name><surname>Abu-zahra</surname><given-names>HS</given-names></name><name><surname>Tojo</surname><given-names>K</given-names></name><name><surname>Ward</surname><given-names>LM</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type-Ib</article-title><source>Nat. Genet</source><year>2005</year><volume>37</volume><issue>1</issue><fpage>25</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">15592469</pub-id></citation></ref><ref id="R166"><label>166</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jan de Beur</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Germain-Lee</surname><given-names>E</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Maret</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>MA</given-names></name></person-group><article-title>Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1</article-title><source>Am. J. Hum. Genet</source><year>2003</year><volume>73</volume><issue>2</issue><fpage>314</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12858292</pub-id></citation></ref><ref id="R167"><label>167</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x000f6;hlich</surname><given-names>LF</given-names></name><name><surname>Bastepe</surname><given-names>M</given-names></name><name><surname>Ozturk</surname><given-names>D</given-names></name><name><surname>Abu-Zahra</surname><given-names>H</given-names></name><name><surname>J&#x000fc;ppner</surname><given-names>H</given-names></name></person-group><article-title>Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><issue>6</issue><fpage>2925</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">17317779</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="F1" position="float"><label>Fig. (1)</label><caption><p>Multiple imprinted sense and antisense transcripts from the complex <italic>GNAS</italic> locus. Exons 1-13 encode Gs&#x003b1; , which is biallelic in most tissues; however, paternal Gs&#x003b1; allele is silenced in a small number of tissues, including the renal proximal tubule, thyroid, and pituitary. From differentially methylated promoters arise several other transcripts, including the maternally expressed NESP55 and the paternally expressed XL&#x003b1;s. Both of these transcripts use individual first exons that splice onto exons 2-13. In addition, the paternal <italic>GNAS</italic> allele gives rise to a transcript termed A/B (also referred to as 1A or 1&#x02019;), which also shares exons 2-13 and is presumed to be non-coding. Note that the A/B transcript contains an ORF (colored grey) that could lead to a translational product, but the existence of endogenous A/B protein is not supported experimentally. Another non-coding transcript is also derived from the paternal <italic>GNAS</italic> allele, but this transcript is made from the antisense strand (AS transcript). Boxes and connecting lines depict exons and introns, respectively. Open rectangles and rectangles filled with CH3 show non-methylated and methylated DMRs, respectively. The distance between AS exon 5 and exon NESP55 is ~19 kb and the distance between exon A/B and exon XL ~35 kb. Maternal (mat) and paternal (pat) <italic>GNAS</italic> products are illustrated above and below the gene structure, respectively, with splicing patterns indicated by broken lines. Filled boxes indicate untranslated sequences.</p></caption><graphic xlink:href="CG-8-398_F1"/></fig><fig id="F2" position="float"><label>Fig. (2)</label><caption><p>Splice variants of Gs&#x003b1;. Alternative splicing of exon 3 leads to Gs&#x003b1;-L and Gs&#x003b1;-S, each of which has subvariants due to alternative splicing of a serine codon at the start of exon 4. Gs&#x003b1;-N1 is formed through the use of an exon that comprises an in-frame termination codon and is located between exons 3 and 4. Boxes and connecting lines depict exons and introns, respectively. The alternatively spliced serine codon is depicted as a circle. Splicing patterns are indicated by broken lines. Filled boxes indicate 5&#x02019; and 3&#x02019; untranslated regions.</p></caption><graphic xlink:href="CG-8-398_F2"/></fig><fig id="F3" position="float"><label>Fig. (3)</label><caption><p>XL&#x003b1;s and its multiple variants. XL&#x003b1;s is derived from a promoter upstream of that which drives the expression of Gs&#x003b1; . Panel A. Alternative splicing leads to different XL&#x003b1;s variants that are analogues to Gs&#x003b1; variants. In addition, an N-terminally extended XL&#x003b1;s variant, termed XXL&#x003b1;s, is made, representing the 5&#x02019; extension of the ORF. For simplicity, GNAS exons located upstream of exon XL are not shown. Panel B. XL&#x003b1;s and XXL&#x003b1;s mRNA include two ORFs each. The second ORF leads to ALEX or ALEXX, respectively.</p></caption><graphic xlink:href="CG-8-398_F3"/></fig><fig id="F4" position="float"><label>Fig. (4)</label><caption><p>Regulation of gene expression from the <italic>GNAS</italic> locus. The maternal <italic>GNAS</italic> allele comprises two germ-line imprint marks, one at the AS promoter and the other at exon A/B. Ablation of the non-methylated, paternal AS promoter causes derepression of NESP55, and ablation of the non-methylated, paternal exon A/B leads to derepression of Gs&#x003b1;; the latter occurs in tissues where the latter is normally silenced from the paternal allele (*). Most familial PHP-Ib cases exhibit isolated loss of <italic>GNAS</italic> exon A/B imprinting. Deletions identified in those cases point to a region within the <italic>STX16</italic> locus, probably around exon 4, as comprising a cis-acting long-range regulatory element that is necessary for the establishment of the maternal exon A/B imprint. All <italic>GNAS</italic> maternal imprints are lost in most sporadic and some familial PHP-Ib cases. Deletions identified in the latter suggest that the NESP55 DMR, which contains not only exon NESP55 but also exons 3 and 4 of the AS transcript, comprises a cis-acting element that controls the imprinting of the entire maternal <italic>GNAS</italic> allele. Arrows indicate the regulatory effects revealed by mutations in PHP-Ib and the study of knockout mouse models. mat, maternal; pat, paternal.</p></caption><graphic xlink:href="CG-8-398_F4"/></fig></floats-wrap></article> 